Skip to Main content
Number of documents

310

Prof Pascal DEMOLY


 

I am a respiratory physician and allergist, Professor of Pulmonology and Head of Department at the University Hospital of Montpellier. I am currently the director of the INSERM research unit IDESP which I built up focusing on epidemiology and public health of chronic non communicable diseases, massive health and environmental data, and modern mathematics.

I am president of the French Allergy Society (2010-2012 and 2022-2024) and current (2019-2023) chair of the French National Council for Allergology. In addition, I am a member of several national and international editorial boards of allergy journals and a full member of the French National Academy of Medicine.

In the last years my research interest has focused mainly on allergy (rhinitis, asthma diagnosis and treatment, allergen immunotherapy, anaphylaxis and drug allergy) where I have extensive experience of lecturing.

I have published more than 900 articles including more than 600 in international peer-reviewed journals (H factor over 100 and citations over 60000, 2018 and 2021 Clarivate Analytics Highly Cited Researcher, category immunology) and I am co-chair of the WHO Collaborating Center on Scientific Classification Support at the University Hospital of Montpellier.


Journal articles299 documents

  • Rhode Ghislaine Nguewo Ngassam, Linnea Ung, Roxana Ologeanu-Taddei, Jorick Lartigau, Pascal Demoly, et al.. An Action Design Research to Facilitate the Adoption of Personal Health Records. Journal of organizational and end user computing, Idea Group Pub, 2022, 34 (4), pp.1-18. ⟨10.4018/JOEUC.288551⟩. ⟨hal-03654736⟩
  • Pablo Rodriguez del Rio, Davide Caimmi, Pilar Rico, Carmen Vidal, Moreno Carmen, et al.. Real‐life report of allergen immunotherapy management during the COVID‐19 outbreak in France and Spain. Clinical and Experimental Allergy, Wiley, 2022, 52 (1), pp.167-170. ⟨10.1111/cea.14043⟩. ⟨hal-03641419⟩
  • Elizabeth Phillips, Pascal Demoly, Maria Torres. Addressing beta‐lactam allergy: A time for action. Allergy, Wiley, 2022, 77 (4), pp.1091-1093. ⟨10.1111/all.15135⟩. ⟨hal-03641093⟩
  • Witchaya Srisuwatchari, Charles Tacquard, Anna Borushko, Simon Viville, Rodolphe Stenger, et al.. Diagnostic performance of serial serum total tryptase measurement to differentiate positive from negative allergy testing among patients with suspected perioperative hypersensitivity. Clinical and Experimental Allergy, Wiley, 2022, 52 (2), pp.334-344. ⟨10.1111/cea.14040⟩. ⟨hal-03641426⟩
  • Dermot Ryan, Bertine Flokstra-de Blok, Evangéline Clark, Clara Gaudin, Myriam Mamodaly, et al.. Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice. Allergy, Wiley, 2022, ⟨10.1111/all.15273⟩. ⟨hal-03641107⟩
  • Pascal Demoly, Christophe Leroyer, Elie Serrano, Annelore Le Maux, Gabrielle Magnier, et al.. The SQ HDM SLIT-Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A "real-life" French study. Clinical and Translational Allergy, BioMed Central, 2022, 12 (3), pp.e12129. ⟨10.1002/clt2.12129⟩. ⟨hal-03641065⟩
  • Christina Krantz, Simone Accordini, Kjell Alving, Angelo Guido Corsico, Pascal M. Demoly, et al.. Cross-sectional study on exhaled nitric oxide in relation to upper airway inflammatory disorders with regard to asthma and perennial sensitization. Clinical and Experimental Allergy, Wiley, 2022, 52 (2), pp.297-311. ⟨10.1111/cea.14019⟩. ⟨hal-03604113⟩
  • Luciana Kase Tanno, Pascal Demoly. Allergy in the World Health Organization's International Classification of Diseases (ICD)‐11. Pediatric Allergy and Immunology, Wiley, 2022, 33 (S27), pp.5-7. ⟨10.1111/pai.13616⟩. ⟨hal-03641132⟩
  • Jean Bousquet, Josep Anto, Wienczyslawa Czarlewski, Tari Haahtela, Susana Fonseca, et al.. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19. Allergy, Wiley, 2021, 76 (3), pp.735-750. ⟨10.1111/all.14549⟩. ⟨hal-03367962⟩
  • Francesca Mori, Natalia Blanca-Lopez, Jean-Christoph Caubet, Pascal Demoly, George Du Toit, et al.. Delayed hypersensitivity to antiepileptic drugs in children. Pediatric Allergy and Immunology, Wiley, 2021, 32 (3), pp.425-436. ⟨10.1111/pai.13409⟩. ⟨hal-03229724⟩
  • Paola Nicoletti, Daniel Carr, Sarah Barrett, Laurence Mcevoy, Peter Friedmann, et al.. Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort. Journal of Allergy and Clinical Immunology, Elsevier, 2021, 147 (5), pp.1830-1837.e15. ⟨10.1016/j.jaci.2020.10.004⟩. ⟨hal-03332301⟩
  • Luciana Kase Tanno, Pascal Demoly. Biologicals for the prevention of anaphylaxis. Current Opinion in Allergy and Clinical Immunology, Lippincott, Williams & Wilkins, 2021, 21 (3), pp.303-308. ⟨10.1097/ACI.0000000000000737⟩. ⟨hal-03641610⟩
  • Amélie Gauthier, Farid Mankouri, Pascal Demoly, Anca Mirela Chiriac. Non-Immediate Maculopapular Erythema To Gadolinium-Based Contrast Agent. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2021, 32 (3), ⟨10.18176/jiaci.0733⟩. ⟨hal-03641264⟩
  • Maria de Filippo, Omar Ali Al Ali, Jean Luc Bourrain, Pascal Demoly, Anca Mirela Chiriac. Immediate flare-up–like reaction of skin tests to betalactams with lymphangitis during drug provocation test. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2021, 9 (2), pp.1021-1023.e1. ⟨10.1016/j.jaip.2020.09.016⟩. ⟨hal-03338248⟩
  • Leyla Barakat, Maria Jose Torres, Elizabeth Phillips, Marco Caminati, Yoon-Seok Chang, et al.. Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2021, 9 (3), pp.1396-1399.e2. ⟨10.1016/j.jaip.2020.10.044⟩. ⟨hal-03231340⟩
  • Nidhal Touati, Barbara Cardoso, Marie Delpuech, Raphaelle Bazire, Nathalie El Kara, et al.. Cephalosporin Hypersensitivity: Descriptive Analysis, Cross-reactivity, and Risk Factors. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2021, 9 (5), pp.1994-2000.e5. ⟨10.1016/j.jaip.2020.11.063⟩. ⟨hal-03169384⟩
  • Pascal Demoly, Catherine Bos, Carmen Vidal. Worsening of chronic house-dust-mite-induced respiratory allergies: An observational survey in three European countries. World Allergy Organization Journal, BMC, 2021, 14 (7), pp.100563. ⟨10.1016/j.waojou.2021.100563⟩. ⟨hal-03333965⟩
  • Witchaya Srisuwatchari, Amélie Gauthier, Marion Menanteau, Pascal Demoly, Anca Mirela Chiriac. Blood pressure measurements could be reduced in number during the drug provocation test. Clinical and Experimental Allergy, Wiley, 2021, 51 (9), pp.1233-1237. ⟨10.1111/cea.13890⟩. ⟨hal-03641486⟩
  • Pascal Demoly, Jonathan Corren, Peter Creticos, Frédéric de Blay, Philippe Gevaert, et al.. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial. Journal of Allergy and Clinical Immunology, Elsevier, 2021, 147 (3), pp.1020 - 1030.e10. ⟨10.1016/j.jaci.2020.07.036⟩. ⟨hal-03613293⟩
  • Luciana Kase Tanno, Pascal Demoly. Epidemiology of anaphylaxis. Current Opinion in Allergy and Clinical Immunology, Lippincott, Williams & Wilkins, 2021, 21 (2), pp.168-174. ⟨10.1097/ACI.0000000000000722⟩. ⟨hal-03647147⟩
  • Anca Mirela Chiriac, Luciana Kase Tanno, Quentin Landry, Anouchka Fillard, Maria Grylaki, et al.. Utility of drug provocation tests in the evaluation of quinolone hypersensitivity reactions. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2021, 9 (5), pp.2097-2100.e2. ⟨10.1016/j.jaip.2020.10.067⟩. ⟨hal-03169431⟩
  • Pascal Demoly. Le vaccin à ARN pour la COVID-19 – quel risque allergique ?. Bulletin de l'Académie nationale de Medecine, 2021, 205 (4), pp.317-320. ⟨10.1016/j.banm.2021.01.020⟩. ⟨hal-03641657⟩
  • Amélie Gauthier, Farid Mankouri, Pascal Demoly, Olivia Sgarbura, Anca Mirela Chiriac. Hypersensitivity reactions to platinum‐based compounds in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Description and management. Allergy, Wiley, 2021, 76 (6), pp.1882-1885. ⟨10.1111/all.14679⟩. ⟨hal-03641638⟩
  • Luciana Kase Tanno, Pascal Demoly, Bryan Martin, Jonathan Berstein, Mario Morais-Almeida, et al.. Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic. World Allergy Organization Journal, BMC, 2021, 14 (2), pp.100515. ⟨10.1016/j.waojou.2021.100515⟩. ⟨hal-03196457⟩
  • Sophie Carra, Michael Schatz, Paul-Michel Mertes, Maria Jose Torres, Florent Fuchs, et al.. Anaphylaxis and Pregnancy: A Systematic Review and Call for Public Health Actions. The Journal of Allergy and Clinical Immunology: In Practice, American Academy of Allergy, Asthma & Immunology, 2021, 9 (12), pp.4270-4278. ⟨10.1016/j.jaip.2021.07.046⟩. ⟨inserm-03617432⟩
  • Theodore Lytras, Anna Beckmeyer-Borowko, Manolis Kogevinas, Hans Kromhout, Anne-Elie Carsin, et al.. Cumulative Occupational Exposures and Lung-Function Decline in Two Large General-Population Cohorts. Annals of the American Thoracic Society, American Thoracic Society, 2021, 18 (2), pp.238-246. ⟨10.1513/AnnalsATS.202002-113OC⟩. ⟨hal-03641819⟩
  • Melissa Anne Russell, Shyamali Dharmage, Elaine Fuertes, Alessandro Marcon, Anne-Elie Carsin, et al.. The effect of physical activity on asthma incidence over 10 years: population-based study. ERJ Open Research, European Respiratory Society, 2021, 7 (1), pp.00970-2020. ⟨10.1183/23120541.00970-2020⟩. ⟨hal-03217337⟩
  • Pascal Demoly, Allison Ramsey. Drug Allergy Management on the Move. The Journal of Allergy and Clinical Immunology: In Practice, American Academy of Allergy, Asthma & Immunology, 2021, 9 (8), pp.3021-3022. ⟨10.1016/j.jaip.2021.04.009⟩. ⟨hal-03641437⟩
  • Luciana Kase Tanno, Evangeline Clark, Myriam Mamodaly, Victoria Cardona, Motohiro Ebisawa, et al.. Food‐induced anaphylaxis morbidity: Emergency department and hospitalization data support preventive strategies. Pediatric Allergy and Immunology, Wiley, 2021, 32 (8), pp.1730-1742. ⟨10.1111/pai.13578⟩. ⟨hal-03641453⟩
  • Cristoforo Incorvaia, Mona Al‐ahmad, Ignacio Ansotegui, Stefania Arasi, Claus Bachert, et al.. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model. Allergy, Wiley, 2021, 76 (4), pp.1041-1052. ⟨10.1111/all.14575⟩. ⟨hal-03613250⟩
  • Luciana Kase Tanno, Nidhal Touati, Salome Allichon, Bryan Martin, Motohiro Ebisawa, et al.. A Proposal from the Montpellier World Health Organization Collaborating Centre for Better Management and Prevention of Anaphylaxis. The Journal of Allergy and Clinical Immunology: In Practice, American Academy of Allergy, Asthma & Immunology, 2021, 9 (2), pp.676-683.e1. ⟨10.1016/j.jaip.2020.09.062⟩. ⟨hal-03641886⟩
  • Jean Bousquet, Oliver Pfaar, Ioana Agache, Anna Bedbrook, Cezmi Akdis, et al.. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy. Clinical and Translational Allergy, BioMed Central, 2021, 11 (4), pp.e12014. ⟨10.1002/clt2.12014⟩. ⟨hal-03642028⟩
  • Davide Caimmi, Catherine Neukirch, Renaud Louis, Olivier Malard, Gabriel Thabut, et al.. Effect of the Use of Intranasal Spray of Essential Oils in Patients with Perennial Allergic Rhinitis: A Prospective Study. International Archives of Allergy and Immunology, Karger, 2021, 182 (3), pp.182-189. ⟨10.1159/000510592⟩. ⟨hal-03338510⟩
  • Elisabet Nerpin, Diogenes Seraphim Ferreira, Joost Weyler, Vivi Schlunnsen, Rain Jogi, et al.. Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status. World Allergy Organization Journal, BMC, 2021, 14 (5), pp.100544. ⟨10.1016/j.waojou.2021.100544⟩. ⟨hal-03337837⟩
  • Roy Gerth van Wijk, Norbert Mülleneisen, Pascal Demoly, Jose Olaguibel, Todor Popov, et al.. The roadmap for allergology in Europe: The European training requirements for the specialty of allergology. Allergy, Wiley, 2021, 76 (5), pp.1588 - 1591. ⟨10.1111/all.14614⟩. ⟨hal-03330744⟩
  • Luciana Kase Tanno, Mariana Castells, Marco Caminati, Gianenrico Senna, Pascal Demoly. Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?. Current Opinion in Allergy and Clinical Immunology, Lippincott, Williams & Wilkins, 2021, 21 (5), pp.411-417. ⟨10.1097/ACI.0000000000000778⟩. ⟨hal-03641441⟩
  • M. Castells, Pascal Demoly, L.K. Tanno. L'anaphylaxie et les vaccins COVID-19. Revue francaise d'allergologie, Elsevier, 2021, 61 (8), pp.8S30-8S35. ⟨10.1016/S1877-0320(21)00439-5⟩. ⟨hal-03641402⟩
  • D. Caimmi, C. Neukirch, Pascal Demoly. Essential oils: what is the clinical tolerance in asthmatic patients?. Journal of Asthma, Informa Healthcare, 2021, pp.1-3. ⟨10.1080/02770903.2021.1888975⟩. ⟨hal-03641687⟩
  • Farid Mankouri, Amélie Gauthier, Witchaya Srisuwatchari, Aurélie Moutou, Anna Borushko, et al.. Hypersensitivity to gadolinium-based contrast agents: A single-center retrospective analysis over 7 years. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2021, 9 (4), pp.1746-1749.e2. ⟨10.1016/j.jaip.2020.11.023⟩. ⟨hal-03223752⟩
  • Sabela Pérez-Codesido, Jean-Luc Bourrain, Pascal Demoly, Anca-Mirela Chiriac. Delayed positive drug provocation tests to beta‐lactams with flare‐up reactions of skin tests sites. Clinical and Experimental Allergy, Wiley, 2021, 51 (3), pp.499-502. ⟨10.1111/cea.13810⟩. ⟨hal-03220494⟩
  • Mathilde Volpato, Stefan Nowak, Jean Luc Bourrain, Pascal Demoly, Engi Ahmed, et al.. The six million dollar man. ERJ Open Research, European Respiratory Society, 2021, 7 (1), pp.00341-2020. ⟨10.1183/23120541.00341-2020⟩. ⟨hal-03130170v2⟩
  • Luciana Kase Tanno, Frédéric Berard, Etienne Beaudoin, Alain Didier, Pascal Demoly. SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center. Vaccines, MDPI, 2021, 9 (6), pp.560. ⟨10.3390/vaccines9060560⟩. ⟨hal-03641471⟩
  • Cristoforo Incorvaia, Mona Al-Ahmad, Ignacio Ansotegui, Stefania Arasi, Claus Bachert, et al.. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model. Allergy, Wiley, 2021, 76 (4), pp.1041-1052. ⟨10.1111/all.14575⟩. ⟨hal-03341922⟩
  • Rhode Ghislaine Nguewo Ngassam, Linnea Ung, Roxana Ologeanu-Taddei, Pascal Demoly, Jorick Lartigau, et al.. Digital Allergy Card: Design and Users’ Perceptions. Studies in Health Technology and Informatics, IOS Press, 2020, 275, pp.226-227. ⟨10.3233/SHTI200729⟩. ⟨hal-03228560⟩
  • Össur Ingi Emilsson, Fredrik Sundbom, Mirjam Ljunggren, Bryndis Benediktsdottir, Judith Garcia-Aymerich, et al.. Association between lung function decline and obstructive sleep apnoea: the ALEC study. Sleep and Breathing, Springer Verlag, In press, ⟨10.1007/s11325-020-02086-1⟩. ⟨hal-02934285⟩
  • Paola Nicoletti, Daniel Carr, Sarah Barrett, Laurence Mcevoy, Peter Friedmann, et al.. Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort. Journal of Allergy and Clinical Immunology, Elsevier, 2020, 147 (5), pp.1830-1837.e15. ⟨10.1016/j.jaci.2020.10.004⟩. ⟨hal-03613304⟩
  • Kai Triebner, Ane Johannessen, Cecilie Svanes, Bénédicte Leynaert, Bryndís Benediktsdóttir, et al.. Describing the status of reproductive ageing simply and precisely: A reproductive ageing score based on three questions and validated with hormone levels. PLoS ONE, Public Library of Science, 2020, 15 (6), pp.e0235478. ⟨10.1371/journal.pone.0235478⟩. ⟨hal-03603929⟩
  • Luciana Kase Tanno, Robert Chalmers, Robert Jacob, Nenad Kostanjsek, Ana Luiza Bierrenbach, et al.. Global implementation of the world health organization's International Classification of Diseases (ICD)‐11: The allergic and hypersensitivity conditions model. Allergy, Wiley, 2020, 75 (9), pp.2206-2218. ⟨10.1111/all.14468⟩. ⟨hal-03610800⟩
  • C. Klingebiel, E. Serrano, A. E. Ehrenberg, C. Agabriel, V Liabeuf, et al.. Natural history and clinical implications of Pru p 7 sensitization: Lessons learned from the follow-up of 160 fruit-allergic patients. Allergy, 2020, 75 (109, SI), pp.257-258. ⟨hal-03149732⟩
  • Luciana Kase Tanno, Pascal Demoly. Anaphylaxis in children. Pediatric Allergy and Immunology, Wiley, 2020, 31 (S26), pp.8-10. ⟨10.1111/pai.13336⟩. ⟨hal-03228400⟩
  • Erla Bjornsdottir, Eva Lindberg, Bryndis Benediktsdottir, Thorarinn Gislason, Vanessa Garcia Larsen, et al.. Are symptoms of insomnia related to respiratory symptoms? Cross-sectional results from 10 European countries and Australia. BMJ Open, BMJ Publishing Group, 2020, 10 (4), pp.e032511. ⟨10.1136/bmjopen-2019-032511⟩. ⟨hal-03605570⟩
  • G. P. Peralta, A. Marcon, A. E. Carsin, M. J. Abramson, S. Accordini, et al.. Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study. Thorax, BMJ Publishing Group, 2020, 75 (4), pp.313-320. ⟨10.1136/thoraxjnl-2019-213880⟩. ⟨hal-03152099⟩
  • Min-Moon Tang, Jie Shen Fok, Bernard Yu-Hor Thong, James Yun, Philip Hei Li, et al.. Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries. Asia Pacific Allergy, 2020, 10 (4), pp.e36. ⟨10.5415/apallergy.2020.10.e36⟩. ⟨hal-03230157⟩
  • Moisés Calderon, Susan Waserman, David Bernstein, Pascal Demoly, Jo Douglass, et al.. Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2020, 8 (9), pp.2920-2936.e1. ⟨10.1016/j.jaip.2020.04.071⟩. ⟨hal-03580096⟩
  • Össur Ingi Emilsson, Fredrik Sundbom, Mirjam Ljunggren, Bryndis Benediktsdottir, Judith Garcia-Aymerich, et al.. Association between lung function decline and obstructive sleep apnoea: the ALEC study. Sleep and Breathing, Springer Verlag, 2020, 25 (2), pp.587-596. ⟨10.1007/s11325-020-02086-1⟩. ⟨hal-03613297⟩
  • J.F. Fontaine, E. Fromentin, S. Lefevre, P. Demoly. L’allergologue face à l’épidémie de COVID-19 : quel impact et quelles précautions prendre ?. Revue francaise d'allergologie, Elsevier, 2020, 60 (8), pp.625-629. ⟨10.1016/j.reval.2020.07.001⟩. ⟨hal-03342572⟩
  • Quentin Landry, Anca Mirela Chiriac, Pascal Demoly, Jean-Luc Bourrain. Reply. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2020, 8 (2), pp.823-824. ⟨10.1016/j.jaip.2019.10.051⟩. ⟨hal-03509332⟩
  • L.K. Tanno, P. Demoly. Preparing international classification of diseases (ICD)-11: Model of allergic and hypersensitivity conditions. Revue francaise d'allergologie, Elsevier, 2020, 60, pp.595 - 599. ⟨10.1016/j.reval.2020.02.237⟩. ⟨hal-03493943⟩
  • Oliver Pfaar, Kostas Karatzas, Katharina Bastl, Uwe Berger, Jeroen Buters, et al.. Pollen season is reflected on symptom load for grass and birch pollen‐induced allergic rhinitis in different geographic areas—An EAACI Task Force Report. Allergy, Wiley, 2020, 75 (5), pp.1099-1106. ⟨10.1111/all.14111⟩. ⟨hal-02861113⟩
  • Bernard Yu-Hor Thong, Michaela Lucas, Hye-Ryun Kang, Yoon-Seok Chang, Philip Hei Li, et al.. Drug hypersensitivity reactions in Asia: regional issues and challenges. Asia Pacific Allergy, 2020, 10 (1), pp.e8. ⟨10.5415/apallergy.2020.10.e8⟩. ⟨hal-03523508⟩
  • Ignacio Javier Ansotegui, Giovanni G. Melioli, Giorgio Walter Canonica, René Maximiliano Gómez, Erika Jensen-Jarolim, et al.. A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020. World Allergy Organization Journal, BMC, 2020, 13 (2), pp.100091. ⟨10.1016/j.waojou.2019.100091⟩. ⟨hal-03227900⟩
  • P. Demoly, L. Kase Tanno. Le modèle de l’anaphylaxie : une nouvelle version de la Classification internationale des maladies de l’Organisation mondiale de la santé pour 2019. Bulletin de l'Académie Nationale de Médecine, Elsevier Masson, 2020, 204, pp.97 - 101. ⟨10.1016/j.banm.2019.06.018⟩. ⟨hal-03489530⟩
  • P. Demoly, M. Demoly, J.L. Bourrain. AdviceMedica, une collaboration intelligente au service des patients. Revue francaise d'allergologie, Elsevier, 2020, 60, pp.24 - 27. ⟨10.1016/j.reval.2019.12.001⟩. ⟨hal-03489623⟩
  • S. Lefevre, I. Bossé, J.F. Fontaine, C. Rolland, J. Just, et al.. Cartographie de l’offre de soins en allergologie en France en 2020. Revue francaise d'allergologie, Elsevier, 2020, 60, pp.119 - 123. ⟨10.1016/j.reval.2020.02.041⟩. ⟨hal-03490976⟩
  • Pascal Demoly, Andrea Matucci, Oliviero Rossi, Carmen Vidal. The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries. Clinical and Translational Allergy, BioMed Central, 2020, 10 (1), pp.27. ⟨10.1186/s13601-020-00331-0⟩. ⟨hal-02934321⟩
  • Philippe Devillier, Pascal Demoly, Mathieu Molimard. Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?. Expert Review of Respiratory Medicine, Taylor & Francis, In press, ⟨10.1080/17476348.2020.1733417⟩. ⟨hal-02512223⟩
  • Ana Dioun Broyles, Aleena Banerji, Sara Barmettler, Catherine Biggs, Kimberly Blumenthal, et al.. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2020, 8 (9), pp.S16-S116. ⟨10.1016/j.jaip.2020.08.006⟩. ⟨hal-03275407⟩
  • N. Touati, B. Cauquil, R. Schrijvers, J.-L. Bourrain, A.M. Chiriac, et al.. Un cas clinique d’une allergie multiple : les conséquences pour le choix d’un antiseptique approprié. Revue francaise d'allergologie, Elsevier, 2020, 60, pp.438 - 442. ⟨10.1016/j.reval.2020.05.007⟩. ⟨hal-03492011⟩
  • Rik Schrijvers, Bárbara Kong Cardoso, Jean Luc Bourrain, Pascal Demoly, Anca Mirela Chiriac. Delayed positive skin tests in patients with immediate hypersensitivity reactions to beta-lactams. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2020, 8, pp.2431 - 2433. ⟨10.1016/j.jaip.2020.03.039⟩. ⟨hal-03491493⟩
  • Giancarlo Pesce, Kai Triebner, Diana A. van der Plaat, Dominique Courbon, Steinar Hustad, et al.. Low serum DHEA-S is associated with impaired lung function in women. EClinicalMedicine, Elsevier, 2020, 23, ⟨10.1016/j.eclinm.2020.100389⟩. ⟨hal-02867471⟩
  • A. E. Carsin, D. Keidel, E. Fuertes, M. Imboden, J. Weyler, et al.. Regular Physical Activity Levels and Incidence of Restrictive Spirometry Pattern: A Longitudinal Analysis of 2 Population-Based Cohorts. American Journal of Epidemiology, Oxford University Press (OUP), 2020, 189 (12), pp.1521-1528. ⟨10.1093/aje/kwaa087⟩. ⟨hal-03172885⟩
  • Pascal Demoly, Isabelle Bossé, Pascal Maigret. Perception and control of allergic rhinitis in primary care. Npj Primary Care Respiratory Medicine, Nature Research 2020, 30 (1), ⟨10.1038/s41533-020-00195-8⟩. ⟨hal-02960232⟩
  • Ludger Klimek, Hans Hoffmann, Ayse Kalpaklioglu, Pascal Demoly, Ioana Agache, et al.. In‐vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper. Allergy, Wiley, 2020, 75 (9), pp.2161-2169. ⟨10.1111/all.14329⟩. ⟨hal-03530169⟩
  • Quentin Landry, Shuchen Zhang, Laetitia Ferrando, Jean Luc Bourrain, Pascal Demoly, et al.. Multiple Drug Hypersensitivity Syndrome in a Large Database. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2020, 8 (1), pp.258-266.e1. ⟨10.1016/j.jaip.2019.06.009⟩. ⟨hal-03359530⟩
  • Luciana Tanno, Thomas Casale, Pascal Demoly. Coronavirus Disease (COVID)-19: World Health Organization Definitions and Coding to Support the Allergy Community and Health Professionals. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2020, 8 (7), pp.2144-2148. ⟨10.1016/j.jaip.2020.05.002⟩. ⟨hal-03577479⟩
  • Anca Mirela Chiriac, Pascal Demoly. Are drugs more dangerous? Drug-induced anaphylaxis across the world. Annals of Allergy, Asthma and Immunology, Elsevier, 2020, 124 (2), pp.146-147. ⟨10.1016/j.anai.2019.11.025⟩. ⟨hal-03380002⟩
  • Abderrahim Oussalah, Vincent Yip, Cristobalina Mayorga, Miguel Blanca, Annick Barbaud, et al.. Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: a PRISMA‐compliant systematic review—An EAACI position paper. Allergy, Wiley, 2020, 75 (5), pp.1069-1098. ⟨10.1111/all.14174⟩. ⟨hal-03394739⟩
  • Ignacio Javier Ansotegui, Giovanni G. Melioli, Giorgio Walter Canonica, Luis R. Caraballo, Elisa Villa, et al.. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organization Journal, BMC, 2020, 13 (2), ⟨10.1016/j.waojou.2019.100080⟩. ⟨hal-03228161⟩
  • Santiago Quirce, Enrico Heffler, Natalia Nenasheva, Pascal Demoly, Andrew Menzies-Gow, et al.. Revisiting Late-Onset Asthma: Clinical Characteristics and Association with Allergy. Journal of Asthma and Allergy, Dove Press, 2020, 13, pp.743-752. ⟨10.2147/JAA.S282205⟩. ⟨hal-03166760⟩
  • E. Carboni, J. Litovsky, E. Manca, A. Deschildre, J. Just, et al.. Les tests de provocation alimentaire dans 4 pays européens : France, Espagne, Italie et Royaume-Uni. Revue francaise d'allergologie, Elsevier, 2020, 60, pp.257 - 259. ⟨10.1016/j.reval.2020.02.023⟩. ⟨hal-03490966⟩
  • Jean Bousquet, Cezmi Akdis, Marek Jutel, Claus Bachert, Ludger Klimek, et al.. Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement. Allergy, Wiley, 2020, 75 (10), pp.2440-2444. ⟨10.1111/all.14302⟩. ⟨hal-03621429⟩
  • Davide Caimmi, Enrica Manca, Elena Carboni, Pascal Demoly. How molecular allergology can shape the management of allergic airways diseases. Current Opinion in Allergy and Clinical Immunology, Lippincott, Williams & Wilkins, 2020, 20 (2), pp.149-154. ⟨10.1097/ACI.0000000000000630⟩. ⟨hal-03482086⟩
  • C Hilger, E Clark, K Swiontek, Am Chiriac, Dp Caimmi, et al.. Anaphylaxis to Bovine Serum Albumin Tissue Adhesive in a Non–Meat-Allergic Patient. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2020, 30 (5), pp.369-371. ⟨10.18176/jiaci.0522⟩. ⟨hal-03528783⟩
  • Nidhal Touati, Am Chiriac, Jean Luc Bourrain, Pascal Demoly. An Unusual Case of Occupational Rhinitis. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2020, 30 (3), pp.207-208. ⟨10.18176/jiaci.0484⟩. ⟨hal-03420840⟩
  • Jean Bousquet, Gabrielle Onorato, Gilles Oliver, Xavier Basagana, Isabella Annesi-Maesano, et al.. Google Trends and pollen concentrations in allergy and airway diseases in France. Allergy, Wiley, 2019, 74 (10), pp.1910-1919. ⟨10.1111/all.13804⟩. ⟨hal-02868130⟩
  • Dunya Nohra, Nicolas Molinari, Pascal Demoly, Anca‐mirela Chiriac. Data‐driven step doses for drug provocation tests to non‐steroidal anti‐inflammatory drugs. Allergy, Wiley, 2019, ⟨10.1111/all.14075⟩. ⟨hal-02556465⟩
  • Luciana Kase Tanno, Robert Chalmers, Ana Luiza Bierrenbach, F. Estelle R. Simons, Bryan Martin, et al.. Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases–11. Journal of Allergy and Clinical Immunology, Elsevier, 2019, 144 (3), pp.627-633. ⟨10.1016/j.jaci.2019.05.013⟩. ⟨hal-02632896⟩
  • Luis Midão, Sinthia Bosnic‐anticevich, Rojin Rajabian‐soderlund, Sylvie Arnavielhe, Isabella Annesi‐maesano, et al.. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study. Clinical and Experimental Allergy, Wiley, 2019, 49 (4), pp.442-460. ⟨10.1111/cea.13333⟩. ⟨hal-02440649⟩
  • Annabelle Bédard, Xavier Basagana, Josep Antó, Judith Garcia-Aymerich, Philippe Devillier, et al.. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. Journal of Allergy and Clinical Immunology, Elsevier, 2019, 144 (1), pp.135-143.e6. ⟨10.1016/j.jaci.2019.01.053⟩. ⟨hal-02867894⟩
  • Sinthia Bosnic‐anticevich, Elísio Costa, Enrica Menditto, Olga Lourenço, Ettore Novellino, et al.. ARIA Pharmacy 2018 "Allergic Rhinitis Care Pathways for Community Pharmacy": AIRWAYS ICPs Initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration Project. Allergy, Wiley, 2019, 74 (7), pp.1219-1236. ⟨10.1111/all.13701⟩. ⟨hal-02624375⟩
  • Mario Olivieri, Nicola Murgia, Anne-Elie Carsin, Joachim Heinrich, Geza Benke, et al.. Effects of smoking bans on passive smoking exposure at work and at home. The European Community respiratory health survey. Indoor Air, Wiley, 2019, pp.ina.12556. ⟨10.1111/ina.12556⟩. ⟨hal-02927509⟩
  • Maria Jose Torres, Gulfem Elif Celik, Paul Whitaker, Marina Atanaskovic-Markovic, Annick Barbaud, et al.. A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy. Allergy, Wiley, 2019, 74 (6), pp.1052--1062. ⟨10.1111/all.13721⟩. ⟨hal-02930944⟩
  • C. Pitsios, M. Tsoumani, M. Bilò, G. Sturm, P. Rodríguez del Río, et al.. Contraindications to immunotherapy: a global approach. Clinical and Translational Allergy, BioMed Central, 2019, 9, pp.45. ⟨10.1186/s13601-019-0285-4⟩. ⟨hal-02297899⟩
  • Dunya Nohra, Rik Schrijvers, Nidhal Touati, Olga Nahas, Najah Ben Fadhel, et al.. Risk factors for positive paracetamol drug provocation testing and procedure optimization. The Journal of Allergy and Clinical Immunology: In Practice, 2019, 7 (6), pp.2045-2048.e2. ⟨10.1016/j.jaip.2019.01.031⟩. ⟨hal-02922712⟩
  • Olga Nahas, Gwladys Mania Byron, Jean Luc Bourrain, Pascal Demoly, Anca Mirela Chiriac. Do we need more proofs for not using the same device for several subsequent skin prick tests?. Clinical and Experimental Allergy, Wiley, 2019, 49 (10), pp.1374-1378. ⟨10.1111/cea.13458⟩. ⟨hal-02859888⟩
  • Anca Mirela Chiriac, Antonino Romano, Najah Ben Fadhel, Francesco Gaeta, Nicolas Molinari, et al.. Follow-up of patients with negative drug provocation tests to betalactams. Clinical and Experimental Allergy, Wiley, In press, ⟨10.1111/cea.13314⟩. ⟨hal-02061544⟩
  • Moises Calderon, Thomas Casale, Pascal Demoly. Validation of Patient-Reported Outcomes for Clinical Trials in Allergic Rhinitis: A Systematic Review. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2019, 7 (5), pp.1450-1461.e6. ⟨10.1016/j.jaip.2019.01.015⟩. ⟨hal-02885052⟩
  • Philippe Devillier, Mathieu Molimard, Xavier Ansolabehere, Isabelle Bardoulat, Nicolas Coulombel, et al.. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France. Allergy, Wiley, 2019, 74 (7), pp.1317-1326. ⟨10.1111/all.13705⟩. ⟨hal-02651315⟩
  • Luciana Kase Tanno, Pascal Demoly. Are outcome measures in allergic diseases relevant for the WHOʼs International Classification of Diseases in allergology?. Current Opinion in Allergy and Clinical Immunology, Lippincott, Williams & Wilkins, 2019, 19 (3), pp.198-203. ⟨10.1097/ACI.0000000000000524⟩. ⟨hal-02921884⟩
  • M. Demoly, J.L. Bourrain, P. Demoly. La complexité médicale appliquée à l’allergologie : causes et solutions. Revue francaise d'allergologie, Elsevier, 2019, 59, pp.336 - 340. ⟨10.1016/j.reval.2019.01.007⟩. ⟨hal-03484918⟩
  • Guillaume Perron, Marc Garcia, François Carbonnel, Florence Trébuchon, Jean-Pierre Daures, et al.. Le Childhood Asthma Control Test améliore les adaptations thérapeutiques recommandées chez les asthmatiques de 6 à 11 ans en médecine générale. Étude prospective comparative randomisée. La Presse Médicale, Elsevier Masson, 2019, 48 (9), pp.e257-e266. ⟨10.1016/j.lpm.2018.10.021⟩. ⟨hal-02563530⟩
  • Giorgio Walter Canonica, Philippe Devillier, Thomas Casale, Pascal Demoly, Catherine Bos, et al.. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data. Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), In press, Epub ahead of print. ⟨10.1080/1744666X.2019.1649597⟩. ⟨hal-02272791⟩
  • Kai Triebner, Simone Accordini, Lucia Calciano, Ane Johannessen, Bryndís Benediktsdóttir, et al.. Exogenous female sex steroids may reduce lung ageing after menopause: A 20-year follow-up study of a general population sample (ECRHS). Maturitas, Elsevier, 2019, 120, pp.29-34. ⟨10.1016/j.maturitas.2018.11.007⟩. ⟨hal-02651254⟩
  • Leyla Barakat, Maria João Vasconcelos, Jean Luc Bourrain, Pascal Demoly, Anca-Mirela Chiriac. IgE-mediated allergy to proton pump inhibitors with both delayed and immediate onset. Asia Pacific Allergy, 2019, 9 (4), ⟨10.5415/apallergy.2019.9.e30⟩. ⟨hal-02543940⟩
  • Rik Schrijvers, Christine Breynaert, Jean-Luc Bourrain, Pascal Demoly, Anca Mirela Chiriac. Patient versus allergy specialist interpretation of a negative workup for suspected iodinated contrast media allergy. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2019, 7 (3), pp.1081-1082. ⟨10.1016/j.jaip.2018.08.023⟩. ⟨hal-02555999⟩
  • Carmen Vidal, Pablo Rodriguez del Rio, Francisco Gude, Thomas Casale, Linda Cox, et al.. Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2019, 7 (4), pp.1298-1305.e3. ⟨10.1016/j.jaip.2018.12.006⟩. ⟨hal-02617495⟩
  • J. Bousquet, S. Arnavielhe, A. Bedbrook, I. Bossé, W. Czarlewski, et al.. Outils numériques pour le suivi des patients allergiques. L’exemple du projet MASK-air. Revue francaise d'allergologie, Elsevier, 2019, 59, pp.172 - 173. ⟨10.1016/j.reval.2019.02.006⟩. ⟨hal-03486340⟩
  • Elisabet Nerpin, Mario Olivieri, Thorainn Gislason, Anna Olin, Rune Nielsen, et al.. Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III. Clinical and Experimental Allergy, Wiley, 2019, 49 (7), pp.969-979. ⟨10.1111/cea.13394⟩. ⟨hal-02869181⟩
  • L. Ung, M. Amouyal, D. Costa, P. Demoly, A.M. Chiriac. Prise en charge de l’anaphylaxie en médecine générale en région Occitanie, à partir d’un questionnaire. Revue francaise d'allergologie, Elsevier, 2019, 59, pp.75 - 82. ⟨10.1016/j.reval.2018.12.002⟩. ⟨hal-03486349⟩
  • A. Boudier, S. Chanoine, S. Accordini, J. M. Anto, X. Basagana, et al.. Data-driven adult asthma phenotypes based on clinical characteristics are associated with asthma outcomes twenty years later. Allergy, Wiley, 2019, 74 (5), pp.953-963. ⟨hal-03285523⟩
  • J Corriger, E Beaudouin, R Rothmann, E Penven, Q Haumonte, et al.. Epidemiological Data on Anaphylaxis in French Emergency Departments. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2019, 29 (5), pp.357-364. ⟨10.18176/jiaci.0348⟩. ⟨hal-02971265⟩
  • Anca Mirela Chiriac, Maria-Joao Vasconcelos, Lisa Izquierdo, Laetitia Ferrando, Olga Nahas, et al.. To challenge or not to challenge: Literature data on the positive predictive value of skin tests to beta-lactams. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2019, 7 (7), pp.2404-2408.e11. ⟨10.1016/j.jaip.2019.01.060⟩. ⟨hal-02880710⟩
  • Theodore Lytras, Manolis Kogevinas, Hans Kromhout, Anne-Elie Carsin, Josep Maria Anto, et al.. Occupational exposures and incidence of chronic bronchitis and related symptoms over two decades: the European Community Respiratory Health Survey. Occupational and Environmental Medicine, BMJ Publishing Group, 2019, pp.oemed-2018-105274. ⟨10.1136/oemed-2018-105274⟩. ⟨hal-02923654⟩
  • A Romano, M Atanaskovic‐markovic, A. Barbaud, Aj Bircher, K. Brockow, et al.. Towards a more precise diagnosis of hypersensitivity to beta‐lactams – an EAACI position paper. Allergy, Wiley, 2019, ⟨10.1111/all.14122⟩. ⟨hal-02531688⟩
  • Claudia Flexeder, Jan-Paul Zock, Deborah Jarvis, Giuseppe Verlato, Mario Olivieri, et al.. Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey. Respiratory Research, BioMed Central, 2019, 20 (1), pp.33. ⟨10.1186/s12931-019-0996-z⟩. ⟨hal-02893484⟩
  • Anne-Elie Carsin, Elaine Fuertes, Emmanuel Schaffner, Debbie Jarvis, Josep Antó, et al.. Restrictive spirometry pattern is associated with low physical activity levels. A population based international study. Respiratory Medicine, Elsevier, 2019, 146, pp.116-123. ⟨10.1016/j.rmed.2018.11.017⟩. ⟨hal-02928017⟩
  • Rongfei Zhu, Jingru Wang, Yuying Wu, Yongshi Yang, Nan Huang, et al.. The Allergic Rhinitis Control Test Questionnaire Is Valuable in Guiding Step-Down Pharmacotherapy Treatment of Allergic Rhinitis. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2019, 7 (1), pp.272-278. ⟨10.1016/j.jaip.2018.05.028⟩. ⟨hal-02549891⟩
  • M. Olivieri, N. Murgia, A. E. Carsin, J. Heinrich, G. Benke, et al.. Effects of smoking bans on passive smoking exposure at work and at home. The European Community respiratory health survey. Indoor Air, Wiley, 2019, 29 (4), pp.670-679. ⟨hal-03162439⟩
  • Össur Ingi Emilsson, Shadi Hägg, Eva Lindberg, Karl Franklin, Kjell Torén, et al.. Snoring and nocturnal reflux: association with lung function decline and respiratory symptoms. ERJ Open Research, European Respiratory Society, 2019, 5 (2), pp.00010--2019. ⟨10.1183/23120541.00010-2019⟩. ⟨hal-02860444⟩
  • Pascal Demoly, Habib Chabane, Jean-François Fontaine, Delphine de Boissieu, Dermot Ryan, et al.. Development of algorithms for the diagnosis and management of acute allergy in primary practice. World Allergy Organization Journal, BMC, 2019, 12 (3), pp.100022. ⟨10.1016/j.waojou.2019.100022⟩. ⟨hal-02868802⟩
  • Jean Bousquet, Ignacio Ansotegui, Josep Antó, Sylvie Arnavielhe, Claus Bachert, et al.. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2019, 7 (8), pp.2511-2523. ⟨10.1016/j.jaip.2019.07.044⟩. ⟨hal-02565239⟩
  • Lucia Diaferio, Anca Mirela Chiriac, Maria Chiara Leoni, Riccardo Castagnoli, Silvia Caimmi, et al.. Skin tests are important in children with β‐lactam hypersensitivity, but may be reduced in number. Pediatric Allergy and Immunology, Wiley, 2019, 30 (4), pp.462-468. ⟨10.1111/pai.13041⟩. ⟨hal-02921557⟩
  • Caroline Klingebiel, Yannick Chantran, Pascal Demoly, Davide Caimmi, Joëlle Birnbaum, et al.. Response to commentary by Drs. Poncet and Sénéchal. Clinical and Experimental Allergy, Wiley, 2019, 00, pp.1 - 2. ⟨10.1111/cea.13441⟩. ⟨hal-02159059⟩
  • C. Carrier, P. Demoly, D. Caimmi. Omalizumab et immunothérapie allergénique : cas clinique et revue de la littérature. Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36 (2), pp.191-196. ⟨10.1016/j.rmr.2018.03.006⟩. ⟨hal-02564239⟩
  • L. Izquierdo, S. Bouhanna, D. Caimmi, P. Demoly, A.M. Chiriac. Allergie à l’hemisuccinate de methylprednisolone chez une patiente atteinte d’une dysfonction des cordes vocales à l’effort. Revue francaise d'allergologie, Elsevier, 2019, 59, pp.394 - 397. ⟨10.1016/j.reval.2019.03.005⟩. ⟨hal-03488025⟩
  • V. Kvedariene, B. Sitkauskiene, L. Tamasauskiene, O. Rudzeviciene, V. Kasiulevicius, et al.. Prevalence of self-reported drug hypersensitivity reactions among Lithuanian children and adults. Allergologia et Immunopathologia, Elsevier España, 2019, 47 (1), pp.32-37. ⟨10.1016/j.aller.2018.05.006⟩. ⟨hal-02556530⟩
  • R Schrijvers, A. Chiriac, Pascal Demoly. Allergy Workup for Suspected Folic Acid Hypersensitivity.. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2019, 25 (3), pp.233-6. ⟨hal-01974893⟩
  • Pascal Demoly, James Li. The Changing World of Drug Allergies. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2019, 7 (7), pp.2154-2155. ⟨10.1016/j.jaip.2019.06.005⟩. ⟨hal-02562145⟩
  • Jean Bousquet, Peter Hellings, Ioana Agache, Flore Amat, Isabella Annesi-Maesano, et al.. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. Journal of Allergy and Clinical Immunology, Elsevier, 2019, 143 (3), pp.864-879. ⟨10.1016/j.jaci.2018.08.049⟩. ⟨hal-02099400⟩
  • Caroline Klingebiel, Yannick Chantran, Rihane Arif‐lusson, Angelica Ehrenberg, Jonas Östling, et al.. Pru p 7 sensitization is a predominant cause of severe, cypress pollen‐associated peach allergy. Clinical and Experimental Allergy, Wiley, 2019, 49 (4), pp.526-536. ⟨10.1111/cea.13345⟩. ⟨hal-02202464⟩
  • Olivier Clément, Pascale Dewachter, Claudie Mouton-Faivre, Camille Nevoret, Laurence Guilloux, et al.. Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study. EClinicalMedicine, Elsevier, 2018, 1, pp.51-61. ⟨10.1016/j.eclinm.2018.07.002⟩. ⟨hal-02304698⟩
  • J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, et al.. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clinical and Translational Allergy, BioMed Central, 2018, 8 (1), ⟨10.1186/s13601-018-0227-6⟩. ⟨hal-02099394⟩
  • J. Bousquet, I. Agache, M. R. Aliberti, R. Angles, Isabella Annesi-Maesano, et al.. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy, Wiley, 2018, Equipe III, 73 (1), pp.77--92. ⟨10.1111/all.13218⟩. ⟨hal-01833325⟩
  • J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, et al.. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clinical and Translational Allergy, BioMed Central, 2018, 8 (1), ⟨10.1186/s13601-018-0227-6⟩. ⟨hal-01915551⟩
  • J. Bousquet, S. Arnavielhe, A. Bedbrook, J. Fonseca, M. Morais Almeida, et al.. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study.. Allergy, Wiley, 2018, 73 (2), pp.505-510. ⟨10.1111/all.13307⟩. ⟨hal-02331715⟩
  • Davide Caimmi, Nour Baïz, Shreosi Sanyal, Soutrik Banerjee, Pascal Demoly, et al.. Discriminating severe seasonal allergic rhinitis. Results from a large nation-wide database. PLoS ONE, Public Library of Science, 2018, 13 (11), pp.e0207290. ⟨10.1371/journal.pone.0207290⟩. ⟨hal-02307907⟩
  • D. Samreth, S. Arnavielhe, F. Ingenrieth, A. Bedbrook, G. Onorato, et al.. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. World Allergy Organization Journal, BMC, 2018, 11 (1), ⟨10.1186/s40413-018-0194-3⟩. ⟨lirmm-01987859⟩
  • J. Bousquet, P. Devillier, J. Anto, M. Bewick, T. Haahtela, et al.. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study.. Allergy, Wiley, 2018, 73 (8), pp.1622-1631. ⟨10.1111/all.13448⟩. ⟨hal-02329488⟩
  • J. Bousquet, P. Devillier, S. Arnavielhe, A. Bedbrook, G. Alexis-Alexandre, et al.. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study.. Allergy, Wiley, 2018, 73 (9), pp.1763-1774. ⟨10.1111/all.13406⟩. ⟨hal-02329777⟩
  • O. Pfaar, S. Bonini, V. Cardona, P. Demoly, T. Jakob, et al.. Perspectives in allergen immunotherapy: 2017 and beyond. Allergy, Wiley, 2018, 73 Suppl 104, pp.5--23. ⟨10.1111/all.13355⟩. ⟨hal-02348992⟩
  • Luciana Kase Tanno, Ignacio Ansotegui, Pascal Demoly. Globalization and anaphylaxis. Current Opinion in Allergy and Clinical Immunology, Lippincott, Williams & Wilkins, 2018, 18 (5), pp.365-369. ⟨10.1097/ACI.0000000000000467⟩. ⟨hal-02370998⟩
  • Pascal Demoly, Mariana Castells. Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium. World Allergy Organization Journal, BMC, 2018, 11 (1), pp.42. ⟨10.1186/s40413-018-0224-1⟩. ⟨hal-01974367⟩
  • Debbie Jarvis, Roger Newson, Christer Janson, Angelo Corsico, Joachim Heinrich, et al.. Prevalence of asthma-like symptoms with ageing. Thorax, BMJ Publishing Group, 2018, 73 (1), pp.37--48. ⟨10.1136/thoraxjnl-2016-209596⟩. ⟨hal-02348858⟩
  • Marianne Lønnebotn, Cecilie Svanes, Jannicke Igland, Karl A. Franklin, Simone Accordini, et al.. Body silhouettes as a tool to reflect obesity in the past. PLoS ONE, Public Library of Science, 2018, 13 (4), pp.e0195697. ⟨10.1371/journal.pone.0195697⟩. ⟨hal-02348852⟩
  • L Kase Tanno, P Demoly. Action Plan to Reach the Global Availability of Adrenaline Auto-Injectors. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2018, 29 (6), ⟨10.18176/jiaci.0346⟩. ⟨hal-02313519⟩
  • Jean Levy, Catherine Neukirch, Isabelle Larfi, Pascal Demoly, Gabriel Thabut. Tolerance to exposure to essential oils exposure in patients with allergic asthma. Journal of Asthma, Informa Healthcare, 2018, 56 (8), pp.853-860. ⟨10.1080/02770903.2018.1493601⟩. ⟨hal-02552140⟩
  • Luciana Tanno, Anouchka Fillard, Quentin Landry, Chahinaze Ramdane, Jean Bourrain, et al.. Ephedrine-induced erythrodermia: Clinical diagnostic procedure and cross-sensitivity. Contact Dermatitis, Wiley, 2018, 79 (1), pp.43-44. ⟨10.1111/cod.12980⟩. ⟨hal-02338725⟩
  • V. Cardona, P. Demoly, S. Dreborg, A. F. Kalpaklioglu, L. Klimek, et al.. Current practice of allergy diagnosis and the potential impact of regulation in Europe. Allergy, Wiley, 2018, 73 (2), pp.323--327. ⟨10.1111/all.13306⟩. ⟨hal-02337221⟩
  • Anca Mirela Chiriac, Youna Wang, Rik Schrijvers, Philippe Jean Bousquet, Thibault Mura, et al.. Designing Predictive Models for Beta-Lactam Allergy Using the Drug Allergy and Hypersensitivity Database. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2018, 6 (1), pp.139 - 148.e2. ⟨10.1016/j.jaip.2017.04.045⟩. ⟨hal-01821274⟩
  • Olivier Vandenplas, Denis Vinnikov, Paul D. Blanc, Ioana Agache, Claus Bachert, et al.. Impact of Rhinitis on Work Productivity: A Systematic Review. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2018, 6 (4), pp.1274-1286. ⟨10.1016/j.jaip.2017.09.002⟩. ⟨hal-01743647⟩
  • A. E. Carsin, D. Keidel, E. Fuertes, M. Imboden, J. Weyler, et al.. Physical activity and incidence of restrictive spirometry pattern in adults. European Respiratory Journal, European Respiratory Society, In press, 52, ⟨10.1183/13993003.congress-2018.PA5289⟩. ⟨hal-02980456⟩
  • Simone Accordini, Lucia Calciano, Ane Johannessen, Laura Portas, Bryndis Benediktsdóttir, et al.. A three-generation study on the association of tobacco smoking with asthma. International Journal of Epidemiology, Oxford University Press (OUP), 2018, 47 (4), pp.1106--1117. ⟨10.1093/ije/dyy031⟩. ⟨hal-02348855⟩
  • Rik Schrijvers, Christine Breynaert, Yazid Ahmedali, Jean-Luc Bourrain, Pascal Demoly, et al.. Skin Testing for Suspected Iodinated Contrast Media Hypersensitivity. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2018, 6 (4), pp.1246--1254. ⟨10.1016/j.jaip.2017.10.040⟩. ⟨hal-02338973⟩
  • J Corriger, E Beaudouin, C Rothmann, E Penven, Q Haumonte, et al.. Epidemiological data of anaphylaxis in french emergency departments. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2018, 29 (5), ⟨10.18176/jiaci.0348⟩. ⟨hal-02313524⟩
  • Luciana Kase Tanno, Ana Luiza Bierrenbach, F. Estelle R. Simons, Victoria Cardona, Bernard Yu-Hor Thong, et al.. Critical view of anaphylaxis epidemiology: open questions and new perspectives. Allergy, Asthma and Clinical Immunology, BioMed Central, 2018, 14 (1), ⟨10.1186/s13223-018-0234-0⟩. ⟨hal-01821283⟩
  • Theodore Lytras, Manolis Kogevinas, Hans Kromhout, Anne-Elie Carsin, Josep M. Antó, et al.. Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health Survey. Thorax, BMJ Publishing Group, 2018, 73 (11), pp.1008--1015. ⟨10.1136/thoraxjnl-2017-211158⟩. ⟨hal-02348853⟩
  • Patrick Blin, Pascal Demoly, Martine Drouet, Bruno Falissard, Séverine Lignot-Maleyran, et al.. An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France. Allergy, Asthma and Clinical Immunology, BioMed Central, 2018, 14, pp.38. ⟨10.1186/s13223-018-0262-9⟩. ⟨hal-02313609⟩
  • Pascal Andujar, Dominique Courbon, Emilie Bizard, Elisabeth Marcos, Serge Adnot, et al.. Smoking, telomere length and lung function decline: a longitudinal population-based study. Thorax, BMJ Publishing Group, 2018, 73 (3), pp.283 - 285. ⟨10.1136/thoraxjnl-2017-210294⟩. ⟨hal-01758291⟩
  • Elaine Fuertes, Anne-Elie Carsin, Josep M. Antó, Roberto Bono, Angelo Guido Corsico, et al.. Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study. Thorax, BMJ Publishing Group, 2018, 73 (4), pp.376--384. ⟨10.1136/thoraxjnl-2017-210947⟩. ⟨hal-02348856⟩
  • Guillaume Pouessel, Paul J. Turner, Margitta Worm, Victoria Cardona, Antoine Deschildre, et al.. Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies. Clinical and Experimental Allergy, Wiley, 2018, 48 (12), pp.1584--1593. ⟨10.1111/cea.13287⟩. ⟨hal-02315109⟩
  • Rodolphe Bourret, Jean Bousquet, Jacques Mercier, Thierry Camuzat, Anna Bedbrook, et al.. MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis.. World Hospitals and Health Services, 2018, pp.36-9. ⟨hal-01767848⟩
  • J. Bousquet, O. Vandenplas, M. Bewick, S Arnavielhe, A. Bedbrook, et al.. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: The MASK Study. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2018, 28 (1), pp.42 - 44. ⟨10.18176/jiaci.0197⟩. ⟨hal-01753349⟩
  • Luciana Kase Tanno, Nicolas Molinari, Sophie Bruel, Jean-Luc Bourrain, Moises A. Calderon, et al.. Field-testing the new anaphylaxis’ classification for the who International Classification of Diseases (ICD)-11 revision. Allergy, Wiley, 2017, 72 (5), pp.820-826. ⟨10.1111/all.13093⟩. ⟨hal-01409034⟩
  • J Bousquet, M Bewick, A Cano, P Eklund, G Fico, et al.. Building bridges for innovation in ageing: synergies between action groups of the EIP on AHA. Journal of Nutrition, Health and Aging, Springer Verlag (Germany), 2017, 21 (1), pp.92-104. ⟨10.1007/s12603-016-0803-1⟩. ⟨hal-03480597⟩
  • D. Caimmi, N. Baiz, L.K. Tanno, P. Demoly, S. Arnavielhe, et al.. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clinical and Experimental Allergy, Wiley, 2017, 47 (12), pp.1526 - 1533. ⟨10.1111/cea.13025⟩. ⟨hal-01753407⟩
  • J. Bousquet, I. Agache, J.M. Anto, K. Bergmann, C. Bachert, et al.. Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy, Wiley, 2017, 72 (8), pp.1261 - 1266. ⟨10.1111/all.13137⟩. ⟨hal-01784791⟩
  • J. Bousquet, G. L. Onorato, C. Bachert, M. Barbolini, A. Bedbrook, et al.. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report. Clinical and Translational Allergy, BioMed Central, 2017, 7, pp.37. ⟨10.1186/s13601-017-0173-8⟩. ⟨hal-01743108⟩
  • Luciana Kase Tanno, Estelle Simons, Isabella Annesi-Maesano, Moises Calderon, Ségolène Aymé, et al.. Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules. Orphanet Journal of Rare Diseases, BioMed Central, 2017, 12 (1), pp.8. ⟨10.1186/s13023-016-0554-4⟩. ⟨inserm-01435328⟩
  • Josep Antó, Jean Bousquet, Mübeccel Akdis, Charles Auffray, Thomas Keil, et al.. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. Journal of Allergy and Clinical Immunology, Elsevier, 2017, 139 (2), pp.388 - 399. ⟨10.1016/j.jaci.2016.12.940⟩. ⟨hal-01784524⟩
  • Anca Mirela Chiriac, Jean Luc Bourrain, Eve Lepicard, Nicolas Molinari, Pascal Demoly. Prevalence of sensitization and allergy to potato in a large population. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2017, 5 (2), pp.507 - 509. ⟨10.1016/j.jaip.2016.12.011⟩. ⟨hal-01777754⟩
  • A.-M. Chiriac, T. Rerkpattanapipat, P.-J. Bousquet, Nicolas Molinari, P. Demoly. Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity. Allergy, Wiley, 2017, 72 (4), pp.552--561. ⟨10.1111/all.13037⟩. ⟨hal-01810370⟩
  • J. Bousquet, D. P. Caimmi, A. Bedbrook, M. Bewick, P. W. Hellings, et al.. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy, Wiley, 2017, 72 (6), pp.857--865. ⟨10.1111/all.13125⟩. ⟨hal-01813358⟩
  • O. Pfaar, K. Bastl, U. Berger, J. Buters, M. Calderon, et al.. Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper. Allergy, Wiley, 2017, 72 (5), pp.713 - 722. ⟨10.1111/all.13092⟩. ⟨hal-01798601⟩
  • Erla Björnsdóttir, Christer Janson, Eva Lindberg, Erna Sif Arnardottir, Bryndís Benediktsdóttir, et al.. Respiratory symptoms are more common among short sleepers independent of obesity. BMJ open respiratory research, BMJ Journals, 2017, 4 (1), pp.e000206. ⟨10.1136/bmjresp-2017-000206⟩. ⟨hal-01743305⟩
  • Luciana Tanno, Thomas Casale, Nikolaos Papadopoulos, Mario Sanchez-Borges, Francis Thiens, et al.. A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: The example of the Joint Allergy Academies. Allergy and Asthma Proceedings, OceanSide Publications; 1999, 2017, 38 (4), pp.54 - 55. ⟨10.2500/aap.2017.38.4063⟩. ⟨hal-01759662⟩
  • O. Pfaar, M.A. Calderon, C.P. Andrews, E. Angjeli, K.C. Bergmann, et al.. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper. Allergy, Wiley, 2017, 72 (7), pp.1035 - 1042. ⟨10.1111/all.13133⟩. ⟨hal-01791121⟩
  • Luciana Kase Tanno, James Sublett, J. Allen Meadows, Moises Calderon, Garry Gross, et al.. Perspectives on the International Classification of Diseases, 11th Revision, developments in allergy clinical practice in the United States. Annals of Allergy, Asthma and Immunology, Elsevier, 2017, 118 (2), pp.127 - 132. ⟨10.1016/j.anai.2016.11.003⟩. ⟨hal-01793332⟩
  • Sophie Colomb, Jean Bourrain, Nathalie Bonardel, Anca Chiriac, Pascal Demoly. Occupational opiate contact dermatitis. Contact Dermatitis, Wiley, 2017, 76 (4), pp.240 - 241. ⟨10.1111/cod.12666⟩. ⟨hal-01775120⟩
  • Luciana Tanno, Tari Haahtela, Moises Calderon, Alvaro Cruz, Pascal Demoly, et al.. Implementation gaps for asthma prevention and control. Respiratory Medicine, Elsevier, 2017, 130, pp.13 - 19. ⟨10.1016/j.rmed.2017.07.006⟩. ⟨hal-01740053⟩
  • Pascal Demoly, Pascal Maigret, Isabelle Elias Billon, François-André Allaert. Allergic rhinitis increases the risk of driving accidents. Journal of Allergy and Clinical Immunology, Elsevier, 2017, 140 (2), pp.614 - 616. ⟨10.1016/j.jaci.2017.01.037⟩. ⟨hal-01777711⟩
  • Sangeeta Dhami, Ulugbek Nurmatov, Graham Roberts, Oliver Pfaar, Antonella Muraro, et al.. Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review. Clinical and Translational Allergy, BioMed Central, 2017, 7, pp.29. ⟨10.1186/s13601-017-0168-5⟩. ⟨hal-01745403⟩
  • O. Nahas, S. Colomb, P. Demoly, J. L. Bourrain. Protein Contact Dermatitis to Chrysanthemum. Journal of Investigational Allergology and Clinical Immunology, ESMON Publicidad, 2017, 27 (5), pp.318--319. ⟨10.18176/jiaci.0172⟩. ⟨hal-01743303⟩
  • M.A. Calderon, C. Vidal, P. Rodríguez del Río, J. Just, O. Pfaar, et al.. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment. Allergy, Wiley, 2017, 72 (3), pp.462 - 472. ⟨10.1111/all.13066⟩. ⟨hal-01808776⟩
  • P. W. Hellings, L. Klimek, C. Cingi, I. Agache, C. Akdis, et al.. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy, Wiley, 2017, 72 (11), pp.1657--1665. ⟨10.1111/all.13200⟩. ⟨hal-01761873⟩
  • Sangeeta Dhami, Ulugbek Nurmatov, Ioana Agache, Susanne Lau, Antonella Muraro, et al.. Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clinical and Translational Allergy, BioMed Central, 2017, 7, pp.32. ⟨10.1186/s13601-017-0167-6⟩. ⟨hal-01745383⟩
  • Luciana Kase Tanno, F. Estelle R. Simons, Mario Sanchez-Borges, Victoria Cardona, Hee-Bom Moon, et al.. Applying prevention concepts to anaphylaxis: A call for worldwide availability of adrenaline auto-injectors. Clinical and Experimental Allergy, Wiley, 2017, 47 (9), pp.1108 - 1114. ⟨10.1111/cea.12973⟩. ⟨hal-01757554⟩
  • Jan L. Brozek, Jean Bousquet, Ioana Agache, Arnav Agarwal, Claus Bachert, et al.. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. Journal of Allergy and Clinical Immunology, Elsevier, 2017, 140 (4), pp.950--958. ⟨10.1016/j.jaci.2017.03.050⟩. ⟨hal-01760836⟩
  • C. Tacquard, O. Collange, P. Gomis, J.-M. Malinovsky, N. Petitpain, et al.. Anaesthetic hypersensitivity reactions in France between 2011 and 2012: the 10th GERAP epidemiologic survey. Acta Anaesthesiologica Scandinavica Supplementum, Wiley-Blackwell, 2017, 61 (3), pp.290 - 299. ⟨10.1111/aas.12855⟩. ⟨hal-01784365⟩
  • Pablo Rodriguez del Rio, Constantinos Pitsios, Marina Tsoumani, Oliver Pfaar, Giannis Paraskevopoulos, et al.. Physicians' experience and opinion on contraindications to allergen immunotherapy: The CONSIT survey. Annals of Allergy, Asthma and Immunology, Elsevier, 2017, 118 (5), pp.621--628.e1. ⟨10.1016/j.anai.2017.02.012⟩. ⟨hal-01761878⟩
  • L. K. Tanno, M. J. Torres, M. Castells, P. Demoly. What can we learn in drug allergy management from World Health Organization's international classifications?. Allergy, Wiley, 2017, ⟨10.1111/all.13335⟩. ⟨hal-01743121⟩
  • M. Shamji, J. Kappen, M. Akdis, E. Jensen-Jarolim, E. Knol, et al.. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy, Wiley, 2017, 72 (8), pp.1156 - 1173. ⟨10.1111/all.13138⟩. ⟨hal-01784702⟩
  • Magnus Ekström, Linus Schiöler, Rune Grønseth, Ane Johannessen, Cecilie Svanes, et al.. Absolute values of lung function explain the sex difference in breathlessness in the general population. European Respiratory Journal, European Respiratory Society, 2017, 49 (5), ⟨10.1183/13993003.02047-2016⟩. ⟨hal-01761513⟩
  • Moisés A. Calderón, Jean Bousquet, G. Walter Canonica, Lars-Olaf Cardell, Dolores Hernandez Rojas, et al.. Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: Time for a change?. Journal of Allergy and Clinical Immunology, Elsevier, 2017, 140 (1), pp.41--52. ⟨10.1016/j.jaci.2017.01.049⟩. ⟨hal-01761505⟩
  • C. Cingi, P. Gevaert, R. Mösges, C. Rondon, V. Hox, et al.. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clinical and Translational Allergy, BioMed Central, 2017, 7, pp.17. ⟨10.1186/s13601-017-0153-z⟩. ⟨hal-01760907⟩
  • Kai Triebner, Bobette Matulonga, Ane Johannessen, Sandra Suske, Bryndís Benediktsdóttir, et al.. Menopause Is Associated with Accelerated Lung Function Decline. American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2017, 195 (8), pp.1058 - 1065. ⟨10.1164/rccm.201605-0968OC⟩. ⟨hal-01798176⟩
  • Luciana Kase Tanno, Moises Calderon, Jeffrey Linzer, Robert Chalmers, Pascal Demoly. Collaboration between specialties for respiratory allergies in the International Classification of Diseases (ICD)-11. Respiratory Research, BioMed Central, 2017, 18 (1), pp.34. ⟨10.1186/s12931-017-0513-1⟩. ⟨inserm-01465127⟩
  • Pascal Demoly, Melina Makatsori, Thomas Casale, Moises Calderon. The Potential Role of Allergen Immunotherapy in Stepping Down Asthma Treatment. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2017, 5 (3), pp.640 - 648. ⟨10.1016/j.jaip.2016.11.024⟩. ⟨hal-01792970⟩
  • Sophie Colomb, Jean Luc Bourrain, Virginie Leduc, Thorsten Burmester, Grégory Marin, et al.. Identification of the larval serum proteins as major fruit fly ( Drosophila melanogaster ) occupational allergens. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2017, 5 (4), pp.1153 - 1155. ⟨10.1016/j.jaip.2017.02.015⟩. ⟨hal-01767715⟩
  • P. Demoly, J. Kleine-Tebbe, D. Rehm. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis. Allergy, Wiley, 2017, 72 (10), pp.1576 - 1578. ⟨10.1111/all.13155⟩. ⟨hal-01777831⟩
  • L.K. Tanno, A. Bierrenbach, M.A. Calderon, A. Sheikh, F. Simons, et al.. Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision. Allergy, Wiley, 2017, 72 (1), pp.120 - 125. ⟨10.1111/all.13006⟩. ⟨hal-01813236⟩
  • Ulrich Wahn, Moises Calderon, Pascal Demoly. Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy. Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2017, 13 (3), pp.283 - 289. ⟨10.1080/1744666X.2017.1277142⟩. ⟨hal-01793080⟩
  • M. Belhassen, P. Demoly, E. Bloch-Morot, G. de Pouvourville, M. Ginoux, et al.. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy, Wiley, 2017, 72 (6), pp.948 - 958. ⟨10.1111/all.13098⟩. ⟨hal-01798479⟩
  • Pablo Rodriguez del Rio, Carmen Vidal, Jocelyne Just, Ana Tabar, Inmaculada Sanchez-Machin, et al.. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment. Pediatric Allergy and Immunology, Wiley, 2017, 28 (1), pp.60 - 70. ⟨10.1111/pai.12660⟩. ⟨hal-01810018⟩
  • Marie Lagreula, Anca-Mirela Chiriac, Maria Chiara Leoni, Pascal Demoly, Davide Caimmi. Risk factors for developing food-induced bronchospasm during oral food challenge. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology, 2017, 28 (6), pp.598--602. ⟨10.1111/pai.12745⟩. ⟨hal-01760465⟩
  • J. Bousquet, M. Bewick, S. Arnavielhe, E. Mathieu-Dupas, R. Murray, et al.. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy, Wiley, 2017, 72 (10), pp.1475 - 1484. ⟨10.1111/all.13177⟩. ⟨hal-01763854⟩
  • Pascal Demoly, Anne Broué-Chabbert, François Wessel, Antoine Chartier. Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey. Allergy, Asthma and Clinical Immunology, BioMed Central, 2016, 12 (1), pp.13. ⟨10.1186/s13223-016-0119-z⟩. ⟨hal-01301635⟩
  • Mathias Cousin, Anca Chiriac, Nicolas Molinari, Pascal Demoly, Davide Caimmi. Phenotypical characterization of children with hypersensitivity reactions to NSAIDs. Pediatric Allergy and Immunology, Wiley, 2016, 27 (7), pp.743-748. ⟨10.1111/pai.12596⟩. ⟨hal-01361516⟩
  • J. Bousquet, P. Hellings, I. Agache, A. Bedbrook, C. Bachert, et al.. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clinical and Translational Allergy, BioMed Central, 2016, 6, pp.47. ⟨10.1186/s13601-016-0137-4⟩. ⟨hal-01822793⟩
  • J. Bousquet, J.M. Anto, M. Akdis, C. Auffray, T. Keil, et al.. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story. Allergy, Wiley, 2016, 71 (11), pp.1513 - 1525. ⟨10.1111/all.12880⟩. ⟨hal-01872911⟩
  • K. Brockow, W. Aberer, M. Atanaskovic-Markovic, S. Bavbek, A. Bircher, et al.. Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy, Wiley, 2016, 71 (11), pp.1533 - 1539. ⟨10.1111/all.12929⟩. ⟨hal-01868510⟩
  • Anca Mirela Chiriac, Pascal Demoly. Allergie et curares. La Presse Médicale, Elsevier Masson, 2016, 45 (9), pp.768 - 773. ⟨10.1016/j.lpm.2016.02.023⟩. ⟨hal-01867857⟩
  • Sangeeta Dhami, Ulugbek Nurmatov, Graham Roberts, Oliver Pfaar, Antonella Muraro, et al.. Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.. Clinical and Translational Allergy, BioMed Central, 2016, 6 (1), pp.12. ⟨10.1186/s13601-016-0099-6⟩. ⟨inserm-01590360⟩
  • Giovanni Passalacqua, Joaquin Sastre, Oliver Pfaar, Ulrich Wahn, Pascal Demoly. Comparison of allergenic extracts from different origins: the value of the FDA’s bioequivalent allergy unit (BAU). Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2016, 12 (7), pp.733 - 739. ⟨10.1080/1744666X.2016.1187561⟩. ⟨hal-01868066⟩
  • C. Mayorga, G. Celik, P. Rouzaire, P. Whitaker, P. Bonadonna, et al.. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy, Wiley, 2016, 71 (8), pp.1103 - 1134. ⟨10.1111/all.12886⟩. ⟨hal-01663032⟩
  • Marek Jutel, Ioana Agache, Sergio Bonini, a Wesley Burks, Moises Calderon, et al.. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. Journal of Allergy and Clinical Immunology, Elsevier, 2016, 137 (2), pp.358 - 368. ⟨10.1016/j.jaci.2015.12.1300⟩. ⟨hal-01879994⟩
  • Rik Schrijvers, Katerina Lagara, Christine Breynaert, Pascal Demoly, Anca Mirela Chiriac. Drug hypersensitivity workup for suspected pristinamycin drug hypersensitivity. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2016, 4 (5), pp.998 - 999.e3. ⟨10.1016/j.jaip.2016.04.010⟩. ⟨hal-01866649⟩
  • Sangeeta Dhami, Ulugbek Nurmatov, Ioana Agache, Susanne Lau, Antonella Muraro, et al.. Allergen immunotherapy for allergic asthma: protocol for a systematic review.. Clinical and Translational Allergy, BioMed Central, 2016, 6 (1), pp.5. ⟨10.1186/s13601-016-0094-y⟩. ⟨inserm-01322498⟩
  • Jean-Marc Malinovsky, Anca Chiriac, Charles Tacquard, Paul Michel Mertes, Pascal Demoly. Allergy to local anesthetics: Reality or myth?. La Presse Médicale, Elsevier Masson, 2016, 45 (9), pp.753 - 757. ⟨10.1016/j.lpm.2016.05.011⟩. ⟨hal-01864694⟩
  • Pascal Demoly, Jörg Kleine-Tebbe. Reply. Journal of Allergy and Clinical Immunology, Elsevier, 2016, 138 (2), pp.635. ⟨10.1016/j.jaci.2016.03.034⟩. ⟨hal-01867876⟩
  • Luciana Tanno, Moises Calderon, Pascal Demoly. New Allergic and Hypersensitivity Conditions Section in the International Classification of Diseases-11. Allergy, Asthma & Immunology Research, Korean Academy of Asthma, Allergy and Clinical Immunology; Korean Academy of Pediatric Allergy and Respiratory Disease, 2016, 8 (4), pp.383-8. ⟨10.4168/aair.2016.8.4.383⟩. ⟨hal-01869692⟩
  • Linda Cox, Alain Didier, Pascal Demoly, Ulrich Wahn, André Pradalier, et al.. Methodological aspects of a meta-analysis of grass pollen allergen sublingual immunotherapy tablets. Journal of Allergy and Clinical Immunology, Elsevier, 2016, 138 (1), pp.314 - 315.e4. ⟨10.1016/j.jaci.2016.01.039⟩. ⟨hal-01871851⟩
  • Jean Bousquet, Holger J. Schünemann, Peter W. Hellings, Sylvie Arnavielhe, Claus Bachert, et al.. MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults. Journal of Allergy and Clinical Immunology, Elsevier, 2016, ⟨10.1016/j.jaci.2016.03.025⟩. ⟨hal-01310973⟩
  • Pascal Demoly, Waltraud Emminger, Dorte Rehm, Vibeke Backer, Lene Tommerup, et al.. Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial. Journal of Allergy and Clinical Immunology, Elsevier, 2016, 137 (2), pp.444 - 451.e8. ⟨10.1016/j.jaci.2015.06.036⟩. ⟨hal-01890194⟩
  • André Amaral, Roger Newson, Michael Abramson, Josep Antó, Roberto Bono, et al.. Changes in IgE sensitization and total IgE levels over 20 years of follow-up. Journal of Allergy and Clinical Immunology, Elsevier, 2016, 137 (6), pp.1788 - 1795.e9. ⟨10.1016/j.jaci.2015.09.037⟩. ⟨hal-01886136⟩
  • Y. Wang, H. Chen, R. Zhu, G. Liu, N. Huang, et al.. Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study. Allergy, Wiley, 2016, 71 (11), pp.1612 - 1619. ⟨10.1111/all.12963⟩. ⟨hal-01865040⟩
  • Ania Carsin, Joana Vitte, Pascal Demoly, Jean-Christophe Dubus. When voluntary paracetamol overdose requires a drug challenge. Annals of Allergy, Asthma and Immunology, Elsevier, 2016, 117 (4), pp.437-438. ⟨hal-01455801⟩
  • Pascal Demoly, Yoshitaka Okamoto, William Yang, Philippe Devillier, Karl-Christian Bergmann. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis. Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2016, 12 (11), pp.1141 - 1151. ⟨10.1080/1744666X.2016.1237288⟩. ⟨hal-01824492⟩
  • Luciana Kase Tanno, Moises Calderon, Nikolaos Papadopoulos, Mario Sanchez-Borges, Lanny Rosenwasser, et al.. Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2016, 4 (4), pp.643 - 649. ⟨10.1016/j.jaip.2015.12.022⟩. ⟨hal-01872964⟩
  • L.K. Tanno, M.A. Calderon, N. Papadopoulos, M. Sanchez-Borges, H.-B. Moon, et al.. Surveying the new Allergic and hypersensitivity conditions chapter of the International Classification of Diseases (ICD)-11. Allergy, Wiley, 2016, 71 (9), pp.1235 - 1240. ⟨10.1111/all.12945⟩. ⟨hal-01867364⟩
  • A. Oussalah, C. Mayorga, M. Blanca, A. Barbaud, A. Nakonechna, et al.. Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review. Allergy, Wiley, 2016, 71 (4), pp.443 - 462. ⟨10.1111/all.12821⟩. ⟨hal-01667064⟩
  • Pascal Demoly, Giovanni Passalacqua, Oliver Pfaar, Joaquin Sastre, Ulrich Wahn. Management of the polyallergic patient with allergy immunotherapy: a practice-based approach. Allergy, Asthma and Clinical Immunology, BioMed Central, 2016, 12 (1), pp.2. ⟨10.1186/s13223-015-0109-6⟩. ⟨inserm-01254137⟩
  • Pascal Demoly, Andrea Matucci, Oliviero Rossi, Carmen Vidal. “A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics”. BMC Pulmonary Medicine, BioMed Central, 2016, 16 (1), pp.85. ⟨10.1186/s12890-016-0246-9⟩. ⟨hal-01322019⟩
  • Pascal Demoly, Anca Chiriac, François-Bernard Michel. Immunothérapies innovantes des maladies allergiques respiratoires. Bulletin de l'Académie Nationale de Médecine, Elsevier Masson, 2016, 200 (3), pp.545-7. ⟨hal-01813962⟩
  • Luciana Kase Tanno, Moises Calderon, James Sublett, Thomas Casale, Pascal Demoly, et al.. Smoothing the transition from International Classification of Diseases, Tenth Revision, Clinical Modification to International Classification of Diseases, Eleventh Revision. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2016, 4 (6), pp.1265 - 1267. ⟨10.1016/j.jaip.2016.06.024⟩. ⟨hal-01825853⟩
  • Luciana Kase Tanno, Moises Calderon, Pascal Demoly, Joint Allergy Academies. Supporting the validation of the new allergic and hypersensitivity conditions section of the World Health Organization International Classification of Diseases-11. Asia Pacific Allergy, 2016, 6 (3), pp.149-56. ⟨10.5415/apallergy.2016.6.3.149⟩. ⟨hal-01836188⟩
  • Luciana Kase Tanno, Robert Chalmers, Moises Calderon, Ségolène Aymé, Pascal Demoly. Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11). Orphanet Journal of Rare Diseases, BioMed Central, 2016, 12 (1), pp.53. ⟨10.1186/s13023-017-0607-3⟩. ⟨inserm-01491431⟩
  • Olga Nahas, Léon Nkashama-Tshiaba, Pascal Demoly, Anca Mirela Chiriac. Anaphylaxis case report to trimethylphloroglucinol (Spasfon®). Allergology International, Wiley, 2016, XXX (1-2), ⟨10.1016/j.alit.2016.04.004⟩. ⟨hal-01321004⟩
  • Maria Torres, Antonino Romano, G. Celik, P. Demoly, D. A. Khan, et al.. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clinical and Translational Allergy, BioMed Central, 2016, 7 (1), pp.7. ⟨10.1186/s13601-017-0144-0⟩. ⟨inserm-01488601⟩
  • Raphaël Chiron, Davide Caimmi, Arunas Valiulis, Isabelle Durieu, Patrick Tejedor, et al.. A model for active and healthy ageing with a rare genetic disease: cystic fibrosis. European Respiratory Journal, European Respiratory Society, 2016, 47 (3), pp.714 - 719. ⟨10.1183/13993003.01237-2015⟩. ⟨hal-01804205⟩
  • Moisés Calderon, Pascal Demoly, Thomas Casale, Cezmi Akdis, Claus Bachert, et al.. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clinical and Translational Allergy, BioMed Central, 2016, 6 (1), pp.41. ⟨10.1186/s13601-016-0131-x⟩. ⟨inserm-01401204⟩
  • J. Bousquet, J. Farrell, G. Crooks, P. Hellings, E. H. Bel, et al.. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clinical and Translational Allergy, BioMed Central, 2016, 6 (1), pp.29. ⟨10.1186/s13601-016-0116-9⟩. ⟨hal-01821925⟩
  • M. Calderon, P. Demoly, L. Tanno. Optimization and simplification of the Allergic and Hypersensitivity conditions classification for the ICD-11. Allergy, Wiley, 2016, 71 (5), pp.671 - 676. ⟨10.1111/all.12834⟩. ⟨hal-01882205⟩
  • Ludger Klimek, Pascal Demoly, David Price. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu. Expert Review of Clinical Pharmacology, Informa Plc, 2016, 9 (5), pp.705 - 714. ⟨10.1586/17512433.2016.1148598⟩. ⟨hal-01881019⟩
  • Luciana Kase Li, Moises Calderon, James Li, Thomas Casale, Pascal Demoly. Updating Allergy and/or Hypersensitivity Diagnostic Procedures in the WHO ICD-11 Revision. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2016, 4 (4), pp.650 - 657. ⟨10.1016/j.jaip.2016.01.015⟩. ⟨hal-01870344⟩
  • Ludger Klimek, Holger Mosbech, Petra Zieglmayer, Dorte Rehm, Brian Sonne Stage, et al.. SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis. Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2016, 12 (4), pp.369 - 377. ⟨10.1586/1744666X.2016.1144473⟩. ⟨hal-01881894⟩
  • Davide Caimmi, Moises Calderon, Jean Bousquet, Pascal Demoly. Allergen Immunotherapy Outcomes and Unmet Needs. Immunology and Allergy Clinics of North America, WB Saunders, 2016, 36 (1), pp.181 - 189. ⟨10.1016/j.iac.2015.08.011⟩. ⟨hal-01886919⟩
  • Philippe Devillier, Jean Bousquet, Stanislas Grassin-Delyle, Hélène Salvator, Pascal Demoly, et al.. Comparison of outcome measures in allergic rhinitis in children, adolescents and adults. Pediatric Allergy and Immunology, Wiley, 2016, 27 (4), pp.375 - 381. ⟨10.1111/pai.12561⟩. ⟨hal-01874308⟩
  • Jean Bousquet, Rodolphe Bourret, Thierry Camuzat, Philippe Augé, Philippe Domy, et al.. Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon). La Presse Médicale, Elsevier Masson, 2015, 44 (1), pp.S6-S22. ⟨10.1016/j.lpm.2015.07.013⟩. ⟨hal-01756022⟩
  • Jean Bousquet, D. Kuh, M. Bewick, T. Standberg, J. Farrell, et al.. Operational definition of Active and Healthy Ageing (AHA): A conceptual framework. Journal of Nutrition, Health and Aging, Springer Verlag (Germany), 2015, 19 (9), pp.955 - 960. ⟨10.1007/s12603-015-0589-6⟩. ⟨hal-01743389⟩
  • Frédéric Cuisinier, J. Bousquet, D. Kuh, M. Bewick, T. Strandberg, et al.. Operative definition of active and healthy ageing (AHA): Meeting report. Montpellier October 20–21, 2014. European Geriatric Medicine, Elsevier, 2015, 6 (2), pp.196 - 200. ⟨10.1016/j.eurger.2014.12.006⟩. ⟨hal-01743411⟩
  • Antoine Avignon, Pierre Fesler, Claire Daien, David Costa, Marie-Christine Picot, et al.. [Living Lab MACVIA. Chronic diseases].. La Presse Médicale, Elsevier Masson, 2015, 44, pp.S47 - S54. ⟨10.1016/j.lpm.2015.07.009⟩. ⟨hal-01757317⟩
  • J. Bousquet, J. M. Anto, M. Wickman, T. Keil, R. Valenta, et al.. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis. Allergy, Wiley, 2015, 70 (9), pp.1062--1078. ⟨10.1111/all.12637⟩. ⟨hal-02005982⟩
  • Jean Bousquet, J. Schunemann, J. Fonseca, B. Samolinski, C. Bachert, et al.. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy, Wiley, 2015, 70 (11), pp.1372-1392. ⟨10.1111/all.12686⟩. ⟨hal-02099381⟩
  • Pascal Demoly, Moises A Calderon, Thomas B Casale, Hans-Jørgen Malling, Ulrich Wahn. "The value of pre-and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis". Clinical and Translational Allergy, BioMed Central, 2015, 5 (1), pp.18. ⟨10.1186/s13601-015-0061-z⟩. ⟨hal-01149005⟩
  • Pascal Demoly, Moises A Calderon, Thomas B Casale, Hans-Jørgen Malling, Ulrich Wahn. The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis. Clinical and Translational Allergy, BioMed Central, 2015, 5, pp.18. ⟨10.1186/s13601-015-0061-z⟩. ⟨hal-01997129⟩
  • N.G. Papadopoulos, J.A. Bernstein, P. Demoly, M. Dykewicz, W. Fokkens, et al.. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy, Wiley, 2015, 70 (5), pp.474-494. ⟨10.1111/all.12573⟩. ⟨hal-02129608⟩
  • Philippe Jean Bousquet, Philippe Devillier, Abir Tadmouri, Kamal Mesbah, Pascal Demoly, et al.. Clinical Relevance of Cluster Analysis in Phenotyping Allergic Rhinitis in a Real-Life Study. International Archives of Allergy and Immunology, Karger, 2015, 166 (3), pp.231--240. ⟨10.1159/000381339⟩. ⟨hal-02005980⟩
  • Stephen Dreskin, Neal Halsey, John Kelso, Robert Wood, Donna Hummell, et al.. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organization Journal, BMC, 2015, 9 (1), pp.32. ⟨10.1186/s40413-016-0120-5⟩. ⟨inserm-01367834⟩
  • Karl-Christian Bergmann, Pascal Demoly, Kathy Abiteboul, Robert Zeldin. Reply: To PMID 24388010. Journal of Allergy and Clinical Immunology, Elsevier, 2015, 135 (1), pp.288-289. ⟨10.1016/j.jaci.2014.09.021⟩. ⟨hal-02166115⟩
  • Pascal Demoly, Michel Aubier, Frédéric de Blay, François Wessel, Pierre Clerson, et al.. Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index – the benefica study. Allergy, Asthma and Clinical Immunology, BioMed Central, 2015, 11 (1), pp.8. ⟨10.1186/s13223-015-0073-1⟩. ⟨hal-01144165⟩
  • Pascal Demoly, Gianni Passalacqua, Moises Calderon, Tarik Yalaoui. Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clinical and Translational Allergy, BioMed Central, 2015, 5 (1), pp.44. ⟨10.1186/s13601-015-0088-1⟩. ⟨inserm-01254140⟩
  • Moises A Calderon, Linda Cox, Thomas B Casale, Ralph Mösges, Oliver Pfaar, et al.. The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey. Allergy, Asthma and Clinical Immunology, BioMed Central, 2015, 11 (1), pp.17. ⟨10.1186/s13223-015-0083-z⟩. ⟨hal-01156541⟩
  • Pascal Demoly, Giovanni Passalacqua, Oliver Pfaar, Joaquin Sastre, Ulrich Wahn. Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence. Allergy, Asthma and Clinical Immunology, BioMed Central, 2015, 12 (1), pp.34. ⟨10.1186/s13223-016-0140-2⟩. ⟨inserm-01349856⟩
  • Luciana Kase Tanno, Moises Calderon, Helen Smith, Mario Sanchez-Borges, Aziz Sheikh, et al.. Dissemination of definitions and concepts of allergic and hypersensitivity conditions. World Allergy Organization Journal, BMC, 2015, 9 (1), pp.24. ⟨10.1186/s40413-016-0115-2⟩. ⟨inserm-01352702⟩
  • Rik Schrijvers, Liesbeth Gilissen, Anca Mirela Chiriac, Pascal Demoly. Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back. Clinical and Translational Allergy, BioMed Central, 2015, 5 (1), pp.31. ⟨10.1186/s13601-015-0073-8⟩. ⟨hal-01194719⟩
  • Moises Calderon, Allan Linneberg, Jörg Kleine-Tebbe, Fréderic de Blay, Dolores Hernandez Fernandez de Rojas, et al.. Respiratory allergy caused by house dust mites: What do we really know?. Journal of Allergy and Clinical Immunology, Elsevier, 2015, 136 (1), pp.38-48. ⟨10.1016/j.jaci.2014.10.012⟩. ⟨hal-02164856⟩
  • Luciana Kase Tanno, Moises Calderon, Pascal Demoly. Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11. Asia Pacific Allergy, 2015, 5 (4), pp.193-6. ⟨10.5415/apallergy.2015.5.4.193⟩. ⟨hal-01900803⟩
  • Axel Villani, Pascal Demoly, Jean-François Nicolas. [Drug hypersensitivity: definitions and mechanisms].. Revue du Praticien (La), J B Bailliere et Fils, 2015, pp.969-71. ⟨hal-01893226⟩
  • Peter Hellings, Antonella Muraro, Wytske Fokkens, Joaquim Mullol, Claus Bachert, et al.. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clinical and Translational Allergy, BioMed Central, 2015, 5 (1), pp.36. ⟨10.1186/s13601-015-0080-9⟩. ⟨hal-01933235⟩
  • Moises Calderon, Jörg Kleine-Tebbe, Allan Linneberg, Fréderic de Blay, Dolores Hernandez Fernandez de Rojas, et al.. House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies. Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2015, 3 (6), pp.843-855. ⟨10.1016/j.jaip.2015.06.019⟩. ⟨hal-01950295⟩
  • L. Tanno, M. Calderon, B. Goldberg, J. Gayraud, J. Bircher, et al.. Constructing a classification of hypersensitivity/allergic diseases for ICD-11 by crowdsourcing the allergist community. Allergy, Wiley, 2015, 70 (6), pp.609-615. ⟨10.1111/all.12604⟩. ⟨hal-02057751⟩
  • Pascal Demoly, Henry Milgrom. By the numbers : bringing new drugs for allergic/hypersensitivity diseases to the market. Current Opinion in Allergy and Clinical Immunology, Lippincott, Williams & Wilkins, 2015, 15 (3), pp.195-196. ⟨10.1097/ACI.0000000000000170⟩. ⟨hal-02006047⟩
  • L. Klimek, H. Hoffmann, H. Renz, Pascal Demoly, T. Werfel, et al.. Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk: a European Perspective. Allergy, Wiley, 2015, 70 (10), pp.1329-1331. ⟨10.1111/all.12676⟩. ⟨hal-01985142⟩
  • Jean Bousquet, Claus Bachert, Jonathan Bernstein, G Walter Canonica, Warner Carr, et al.. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps. Expert Opinion on Pharmacotherapy, Taylor & Francis, 2015, 16 (6), pp.913-928. ⟨10.1517/14656566.2015.1020789⟩. ⟨hal-02023498⟩
  • Luciana Kase Tanno, Moises Calderon, Nikolaos Papadopoulos, Pascal Demoly. Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs. Clinical and Translational Allergy, BioMed Central, 2015, 5 (1), pp.20. ⟨10.1186/s13601-015-0063-x⟩. ⟨hal-01983120⟩
  • David Price, Pete Smith, Peter Hellings, Nikos Papadopoulos, Wytske Fokkens, et al.. Current controversies and challenges in allergic rhinitis management. Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2015, 11 (11), pp.1205-1217. ⟨10.1586/1744666X.2015.1081814⟩. ⟨hal-01952348⟩
  • J. Bousquet, A Addis, I Adcock, I. Agache, A Agusti, et al.. Integrated care pathways for airway diseases (AIRWAYS-ICPs). European Respiratory Journal, European Respiratory Society, 2014, 60, ⟨10.1183/09031936.00014614⟩. ⟨hal-02565409⟩
  • Jean Bousquet, Christian Jorgensen, Michel Dauzat, Alfredo Cesario, Thierry Camuzat, et al.. Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies.. Current Pharmaceutical Design, Bentham Science Publishers, 2014, 20 (38), pp.5928-44. ⟨10.2174/1381612820666140314115505⟩. ⟨hal-01952751⟩
  • Philippe Devillier, Jean-François Dreyfus, Pascal Demoly, Moisés Calderón. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Medicine, BioMed Central, 2014, 12 (1), pp.71. ⟨inserm-00990904⟩
  • Pascal Demoly, Anca Mirela Chiriac, Benoît Berge, Michel Rostin. Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response. Allergy, Asthma and Clinical Immunology, BioMed Central, 2014, 10, pp.29. ⟨10.1186/1710-1492-10-29⟩. ⟨hal-01307379⟩
  • Pascal Demoly, Moises Calderon, Thomas Casale, Glenis Scadding, Isabella Annesi-Maesano, et al.. Assessment of disease control in allergic rhinitis.. Clinical and Translational Allergy, BioMed Central, 2013, 3 (1), pp.7. ⟨10.1186/2045-7022-3-7⟩. ⟨inserm-00807334⟩
  • Anca Mirela Chiriac, Pascal Demoly. Drug provocation tests: up-date and novel approaches.. Allergy, Asthma and Clinical Immunology, BioMed Central, 2013, 9 (1), pp.12. ⟨10.1186/1710-1492-9-12⟩. ⟨inserm-00812757⟩
  • Mark Small, James Piercy, Pascal Demoly, Helen Marsden. Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey.. Clinical and Translational Allergy, BioMed Central, 2013, 3 (1), pp.33. ⟨10.1186/2045-7022-3-33⟩. ⟨inserm-00875331⟩
  • Moisés Calderón, Alfred Frankland, Pascal Demoly. Allergen immunotherapy and allergic rhinitis: false beliefs.. BMC Medicine, BioMed Central, 2013, 11 (1), pp.255. ⟨10.1186/1741-7015-11-255⟩. ⟨inserm-00932557⟩
  • Nikolaos Papadopoulos, Ioana Agache, Sevim Bavbek, Beatrice Bilo, Fulvio Braido, et al.. Research needs in allergy: an EAACI position paper, in collaboration with EFA.. Clinical and Translational Allergy, BioMed Central, 2012, 2 (1), pp.21. ⟨10.1186/2045-7022-2-21⟩. ⟨inserm-00771547⟩
  • Jean Bousquet, Josep Anto, Pascal Demoly, Holger Schünemann, Alkis Togias, et al.. Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.. International Archives of Allergy and Immunology, Karger, 2012, 158 (3), pp.216-31. ⟨10.1159/000332924⟩. ⟨inserm-00788048⟩
  • Moises Calderon, Pascal Demoly, Roy Gerth van Wijk, Jean Bousquet, Aziz Sheikh, et al.. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.. Clinical and Translational Allergy, BioMed Central, 2012, 2 (1), pp.20. ⟨10.1186/2045-7022-2-20⟩. ⟨inserm-00761011⟩
  • Silvia Caimmi, Céline Sanfiorenzo, Davide Caimmi, Philippe-Jean Bousquet, Raphael Chiron, et al.. Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics. Clinical and Translational Allergy, BioMed Central, 2012, 2 (1), pp.10. ⟨10.1186/2045-7022-2-10⟩. ⟨inserm-00731481⟩
  • J. Bousquet, L. Heinzerling, C. Bachert, N. G. Papadopoulos, P. J. Bousquet, et al.. Practical guide to skin prick tests in allergy to aeroallergens.. Allergy, Wiley, 2011, 67 (1), pp.18-24 ⟨10.1111/j.1398-9995.2011.02728.x⟩. ⟨hal-00644099⟩
  • A. Chiriac, Fares Gouzi, J. Bousquet, P. Demoly. Acute loss of lung function without wheezing during bee venom immunotherapy. Allergy, Wiley, 2011, 66 (9), pp.1258-1259. ⟨10.1111/j.1398-9995.2011.02603.x⟩. ⟨inserm-02398249⟩
  • Jean Bousquet, H. J. Schünemann, T. Zuberbier, C. Bachert, C. E. Baena-Cagnani, et al.. Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper.. Allergy, Wiley, 2010, 65 (10), pp.1212-21. ⟨10.1111/j.1398-9995.2010.02480.x⟩. ⟨hal-00595859⟩
  • S. Rouve, A. Didier, P. Demoly, R. Jankowsky, J.-M. Klossek, et al.. Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity.. Rhinology, International and European Rhinologic Societies, 2010, 48 (3), pp.285-91. ⟨10.4193/Rhin09.208⟩. ⟨hal-00598337⟩
  • J. Bousquet, W. Fokkens, P. Burney, Sr Durham, C. Bachert, et al.. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper.. Allergy, Wiley, 2008, 63 (7), pp.842-853. ⟨10.1111/j.1398-9995.2008.01715.x⟩. ⟨hal-00409869⟩
  • J. Bousquet, N. Khaltaev, A. A. Cruz, J. Denburg, W. J. Fokkens, et al.. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).. Allergy, Wiley, 2008, 63 Suppl 86, pp.8-160. ⟨10.1111/j.1398-9995.2007.01620.x⟩. ⟨hal-00596392⟩
  • Dominique Hillaire-Buys, Jean-Pierre Blayac, Hélène Peyrière, Hélène Breton, Marylène Cociglio, et al.. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. British Journal of Dermatology, Wiley, 2006, 155 (2), pp.422-428. ⟨10.1111/j.1365-2133.2006.07284.x⟩. ⟨hal-02910482⟩
  • Said Benhamed, Marie-Christine Picot, Dominique Hillaire-Buys, Jean-Pierre Blayac, Pierre Dujols, et al.. Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions. European Journal of Clinical Pharmacology, Springer Verlag, 2005, 61 (7), pp.537-541. ⟨10.1007/s00228-005-0962-1⟩. ⟨hal-03061616⟩
  • M. Mondain, S. Restituito, V. Vincenti, Q. Gardiner, A. Uziel, et al.. Adenovirus-mediated in vivo gene transfer in guinea pig middle ear mucosa. Human Gene Therapy, Mary Ann Liebert, 1998, 9 (8), pp.1217--1221. ⟨10.1089/hum.1998.9.8-1217⟩. ⟨hal-02196861⟩
  • C. Jorgensen, P. Demoly, D. Noel, M. Mathieu, M. Piechaczyc, et al.. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 1997, 24 (11), pp.2076--2079. ⟨hal-02194547⟩
  • N. Basset-Seguin, P. Demoly, J. P. Moles, A. Tesnieres, C. Gauthier-Rouviere, et al.. Comparative analysis of cellular and tissular expression of c-fos in human keratinocytes: evidence of its role in cell differentiation. Oncogene, Nature Publishing Group, 1994, 9 (3), pp.765--71. ⟨hal-02193238⟩

Conference papers6 documents

  • Rhode Ghislaine Nguewo Ngassam, Linnea Ung, Roxana Ologeanu-Taddei, Pascal Demoly, Jorick Lartigau, et al.. Digital Allergy Card: Design and users’ perceptions. Special Topic Conference (STC 2020) EFMI, Nov 2020, Montpellier, France. ⟨hal-03128364⟩
  • Marcin Trzmielewski, Davide Caimmi, Pascal Demoly, Luciana Tanno. Quésaco ? Le discours du médecin m'est passé sous le nez !. 15ème Congrès Francophone d'Allergologie, Jul 2020, Paris, France. ⟨hal-02928499⟩
  • C. Klingebiel, Yannick Chantran, R. Arif-Lusson, A.E. Ehrenberg, J. Ostling, et al.. Pru P 7 is a major peach allergen associated with cypress pollen sensitization and increased risk of severe reactions. Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), 2019, Lisbon, Portugal. pp.46-47. ⟨hal-02479752⟩
  • Marcin Trzmielewski, Davide Paolo Caimmi, Luciana Kase Tanno, Pascal Demoly. What did the doctor say? Patients' comprehension of allergy consultations in a French university hospital. World Allergy Congress (WAC) 2019, Dec 2019, Lyon, France. ⟨hal-02465552⟩
  • Marcin Trzmielewski, Pascal Demoly, Luciana Tanno, Davide Caimmi, Claudio Gnoli. Information and Data in Allergology: Theoretical and Methodological Proposals for Building a Knowledge Organization Model dedicated to the Design of Info-communication Devices. ISKO Low Countries 2019 Conference, Jun 2019, Bruxelles, Belgium. ⟨hal-02466206⟩
  • Mc Leoni, D Caimmi, Anca Chiriac, Mp Demoly, Pascal Demoly. Severe peach allergy in patients non-sensitized to Pru p 3. Food Allergy and Anaphylaxis Meeting (FAAM 2013) Nice, France. 7-9 February 2013, Feb 2013, France. pp.P150, ⟨10.1186/2045-7022-3-S3-P150⟩. ⟨inserm-00848071⟩

Other publications4 documents

  • Marcin Trzmielewski, Davide Caimmi, Luciana Tanno, Laetitia Ferrando, Didier Ducarteron, et al.. What did the doctor say? Patients’ comprehension of allergy consultations in a French university hospital. 2020, pp.100365. ⟨10.1016/j.waojou.2020.100365⟩. ⟨hal-03226743⟩
  • M. Trzmielewski, D. Caimmi, P. Demoly, L. Tanno. Quésaco ? Le discours du médecin m’est passé sous le nez !. 2020, pp.369-370. ⟨10.1016/j.reval.2020.02.188⟩. ⟨hal-03226741⟩
  • C. Barnig, A. Baron-Thurotte, A. Barbaud, E. Beaudouin, F. de Blay, et al.. Recommandations de la Société Française d’Allergologie. Indications des actes allergologiques en Hôpital de Jour. 2017, pp.442 - 463. ⟨10.1016/j.reval.2017.05.002⟩. ⟨hal-01685263⟩
  • Maria Chiara Leoni, Marie Pascale Demoly, Anca Mirela Chiriac, Gian Luigi Marseglia, Pascal Demoly. PD24 - Oral food challenges to peanut in the pediatric population at the Allergy Department of the University Hospital of Montpellier, France. 2014, pp.P24. ⟨inserm-00953660⟩

Preprints, Working Papers, ...1 document

  • Christophe Pison, Jean Bousquet, Pascal Demoly. Data-driven adult asthma phenotypes based on clinical characteristics are associated with asthma outcomes twenty years later.. 2019. ⟨hal-01962361⟩